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3«FOR EVERY AFFECTION OF THE MIND THAT IS ATTENDED WITH EITHER PAIN OR PLEASURE,
HOPE OR FEAR, IS THE CASE OF AN AGITATION WHOSE INFLUENCE EXTENDS TO THE HEART,
AND THERE INDUCES CHANGES FROM THE NATURAL CONSTITUTION, IN THE TEMPERATURE,
THE PULSE AND THE REST, WHICH IMPAIRING ALL NUTRITION IN ITS SOURCE AND ABATING
THE POWERS AT LARGE, IT IS NO WONDER THAT VARIOUS FORMS OF INCURABLE DISEASE IN
THE EXTREMITIES AND IN THE TRUNK ARE THE CONSEQUENCE, INASMUCH AS IN SUCH
CIRCUMSTANCE THE WHOLE BODY LABOURS UNDER THE EFFECTS OF VITIATED NUTRITION
AND A WANT OF NATIVE HEAT.»
FROM ‘EXERCITATIO ANATOMICA DE MOTU CORDIS ET SANGUINIS IN ANIMALIBUS’, BY
WILLIAM HARVEY (1578-1657), QUOTED FROM (159)
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HF High frequency 
HR Heart rate 
HRV Heart rate variability 
HUT Head-up tilt-test 
LBNP Lower body negative pressure 
LF Low frequency 
MBP Mean arterial blood pressure 
SBP Systolic blood pressure 
SI Stroke index 
TPRI Total peripheral resistance index 
TT Tympanic temperature 
List of appended papers
Paper I. Wyller VB, Thaulow E, Amlie JP. Chronic fatigue and orthostatic
intolerance effectively treated by propranolol. J Pediatr 2007, in press.
Paper II. Wyller VB, Due R, Saul JP, Amlie JP, Thaulow E. Usefulness of an
abnormal cardiovascular response during low-grade head-up tilt-test for
discriminating adolescents with chronic fatigue from healthy controls. Am J Cardiol
2007; 99: 997-1001
Paper III. Wyller VB, Saul JP, Amlie JP, Thaulow E. Sympathetic predominance of
cardiovascular regulation during mild orthostatic stress in adolescents with chronic
fatigue. Clin Physiol Funct Imaging 2007, in press.
Paper IV. Wyller VB, Saul JP, Walløe L, Thaulow E. Enhanced sympathetic
response during orthostatic stress and attenuated sympathetic responses during
isometric exercise may account for clinical symptoms in adolescents with chronic
fatigue. Eur J Appl Physiol 2007, in press.
Paper V. Wyller VB, Godang K, Mørkrid L, Saul JP, Thaulow E, Walløe L. Abnormal
thermoregulatory responses in adolescents with chronic fatigue syndrome: relation
to clinical symptoms. Pediatrics 2007, in press.
5Contents
Preface and acknowledgements 7
1 Introduction 9
1.1 Clinical starting point – an overview of chronic fatigue syndrome 9
 1.1.1 Definitions and terminology 9
 1.1.2 Epidemiology and history 11
 1.1.3 Clinical features  11
 1.1.4 Treatment and prognosis 14
1.2 Basic science starting point – an overview of the autonomic nervous 
system 
15
 1.2.1 Structure and function of the autonomic nervous system 15
 1.2.2 Homeostatic regulatory systems  20
1.3 The pathophysiology of chronic fatigue syndrome – epistemological 
issues, prior findings and research questions 
24
 1.3.1 Epistemological considerations and premises 24
 1.3.2 Prior research on CFS pathophysiology 26
 1.3.3 Aims and research questions 33
2 Material and methods 35
2.1 Material  35
 2.1.1 CFS patients  35
 2.1.2 Healthy controls 37
2.2 Methods 38
 2.2.1 Experimental protocols 38
 2.2.2 Data analyses 43
 2.2.3 Ethical and legal considerations 45
3 Results 47
3.1 Subjects 47
3.2 Experimental results 47
 3.2.1 Symptoms of altered cardiovascular and thermoregulatory 
autonomic control 
49
 3.2.2 Cardiovascular, neuroendocrine and thermoregulatory variables 
during supine rest 
51
 3.2.3 Cardiovascular responses to orthostatic stress alone and 
combined with isometric exercise 
51
 3.2.4 Cardiovascular, neuroendocrine and thermoregulatory responses 
to local cold stress 
52
 3.2.5 Comparison of CFS patients with sedentary controls 53
 3.2.6 Quality of data during LBNP with handgrip 54
64 Discussion 57
4.1 Answers to the research questions  57
 4.1.1 Symptoms of altered cardiovascular and thermoregulatory 
autonomic control 
57
 4.1.2 Cardiovascular, neuroendocrine and thermoregulatory variables 
during supine rest  
58
 4.1.3 Cardiovascular responses to orthostatic stress 59
 4.1.4 Cardiovascular, neuroendocrine and thermoregulatory responses 
to local cold stress 
59
 4.1.5 Concluding remarks 60
4.2 Possible explanations of altered sympathetic nerve activity in CFS 61
 4.2.1 Hypovolemia 61
 4.2.2 Oxidative stress 62
 4.2.3 Postural orthostatic tachycardia syndrome (POTS) 62
 4.2.4 Sedentary deconditioning 63
 4.2.5 Gravitational deconditioning 65
 4.2.6 Disturbances of CNS autonomic control 66
 4.2.7 Concluding remarks 67
4.3 Methodological considerations and study limitations 68
 4.3.1 Recruitment 68
 4.3.2 Experimental protocols 68
 4.3.3 Quality of data 70
5 Towards a unifying theory of the chronic fatigue syndrome 71
5.1. A conceptual framework 71
 5.1.1 The stress theory of Goldstein 71
 5.1.2 Supplemental stress theories 73
 5.1.3 The concept of CFS as a disorder of sustained arousal 74
5.2 The CFS sustained arousal theory 75
 5.2.1 Predisposing factors  75
 5.2.2 Precipitating factors 77
 5.2.3 Consequences of the disease process and perpetuating factors 79
 5.2.4 A unifying model of CFS pathophysiology 86
 5.2.5 Suggestions for further research 90
6 References 93
Appendix 119
Paper I 121
Paper II 127
Paper III 139
Paper IV 155
Paper V 177
7Preface and acknowledgements
This thesis has been inspired, adjusted and enriched by the clinical encounter with
individual CFS patients. In particular, I want to thank those who patiently participated
in the experiments, and thereby contributed to a better understanding of – and hopefully
better care for – their successors. I also thank the healthy controls, each of them
idealistically devoting one day to the benefit of medical research.
However, inspiration and access to volunteers would not have been enough. The
launching of a research project exploring CFS pathophysiology required the joint effort
of a visionary, enthusiastic clinical academic and a precise, realistic natural scientist.
My supervisors, Erik Thaulow, Dept. of Paediatrics, Rikshospitalet and Lars Walløe,
Dept. of Physiology, University of Oslo, are ‘archetypes’ in this regard, whereas Phil
Saul, Dept. of Pediatrics, Medical University of South Carolina – being both a pediatric
cardiologist and a physiologist – personify a synthesis. I am most grateful for their
continuous support, supervision and advice.
Every researcher meets an endless row of practical obstacles. Elisabeth Getz, Dept. of
Paediatrics, Rikshospitalet and Torun Flatebø, Dept. of Physiology, University of Oslo
have provided invaluable technical assistance - my deepest thanks.
Further, I am indebted to Jan P. Amlie, Medical Outpatient Clinic, Rikshospitalet, who
taught me about head-up tilt tests; Helene Gjone, Dept. of Child Psychiatry,
Rikshospitalet, who performed psychiatric assessments of the CFS patients and provided
me with supplemental perspectives of their complaints; Kristin Godang, Dept. of
Endocrinology and Lars Mørkrid, Dept. of Medical Biochemistry, Rikshospitalet, who
performed and interpreted the neuroendocrine analyses; Reidar Due, Dept. of Paediatrics,
Rikshospitalet, who participated in the assessment of some of the CFS patients; Per
Morten Fredriksen, Dept. of Paediatrics, Rikshospitalet, who performed tilt tests and
exercise tolerance tests in some individuals; Jonny Hisdal, Aker University Hospital,
who introduced me to the LBNP technique; Kari Toverud, a Certified Medical Illustrator
who provided the graphic artwork in this thesis; John Fredriksen and wife, who provided
financial support for the tilt-test experiments; Gunnar Nicolaysen, the Head of the
Dept. of Physiology, University of Oslo, and Sverre O. Lie and Terje Rootwelt, the
former and present Head of the Dept. of Paediatrics, Rikshospitalet, who have been
most supportive of this project.
8I am also grateful for the support from all colleagues and friends at the Dept. of Paedi-
atrics, Rikshospitalet and Dept. of Physiology, University of Oslo. Finally, I thank all
dear members of family at Wilhelmshøi for their continuous encouragement: My mother
Kari, my father Thomas, my brother (and colleague) Torgeir, my sister-in-law Liv, and
their children Tuva Elisabeth, Guro Marie and Fredrik August.
Nordstrand, Oslo, February 2007
Vegard Bruun Wyller
91 Introduction
This thesis has two ‘starting points’ – one in the clinic, related to encounters with
chronic fatigued patients (see paper I), and one in the basic sciences, related to a search
for methods suited for exploring the pathophysiology of chronic fatigue syndrome.
Each of these areas will be thoroughly elaborated on throughout the next two sections,
followed by a paragraph addressing epistemological issues, prior findings, and research
questions.
1.1 Clinical starting point – an overview of chronic fatigue
syndrome
1.1.1 Definitions and terminology
Chronic fatigue syndrome (CFS) is a common and – in many instances – severely
disabling disease (2, 318). Different case-definitions exists; most widespread – in
research as well as in clinical practice - is the one developed by the US Centers for
Disease Control and Prevention, commonly referred to as the CDC-definition (142)
(Table 1). Here, the main criterion is persistent or relapsing fatigue of 6 months duration
or more, severely affecting daily activities. In addition, patients should report at least 4
of 8 specific accompanying symptoms.
Other case-definitions in current use are the so-called Oxford-definition (360), the
Australian definition (248), and the Canadian definition (55). None of these deviate
strongly from the CDC-definition, but there are important nuances. More specifically,
the Oxford-definition requires the presence of ‘mental fatigue’ and accepts symptoms
that might indicate a psychiatric disorder; the Australian definition does not require a
new or definite onset of fatigue; whereas the Canadian definition excludes patients
with any symptoms of mental illness.
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The different case-definitions – and their similiarities and differences - have been sub-
stantially debated. Two questions are of particular importance in this thesis:
- Are the different definitions more or less interchangeable, or do they define dis-
tinctly different subgroups of patients? To put it even more pointedly: Is there a
correspondence between a certain case definition and a particular mechanism of
disease?
- How valid are these definitions? More specifically: is the CDC-definition valid
when applied to adolescents?
These problems will be addressed more in depth later (see 1.3.1).
The complexity is even higher when it comes to terminology. Chronic fatigue syndrome
(CFS) is the preferred term among most scientists and clinicians, and will also be used
in this thesis. Myalgic encephalomyelitis (ME) is commonly used among patient
organizations (318). Whether CFS and ME designate identical or different (though
related) disorders, is widely disputed. It has been maintained that neurasthenia –
primarily used within the field of psychiatry – is a synonymous term (434). Other less
common terms are post-infectious fatigue syndrome and chronic fatigue and immune
dysfunction syndrome. Some argue that even entities such as gulf war-syndrome and
multiple chemical sensitivity should be added to this list (25).
Table 1. CDC-definition of chronic fatigue syndrome* 
Main criteria (patients must adhere to all) 
Persistent or relapsing fatigue of 6 months duration or more 
Fatigue severly affects daily activities 
Fatigue is not explained by any concurrent somatic or psychiatric condition 
Fatigue is new or definite in onset 
Fatigue is not the result of ongoing exertion 
Fatigue is not alleviated by rest 
Additional criteria (patients must adhere to at least 4)
Impaired memory and/or concentration 
Sore throat 
Tender cervical and/or axillary lymph nodes 
Muscle pain 
Multi-joint pain
New headaches
Unrefreshing sleep 
Post-exertional malaise 
* Adapted from (142) 
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1.1.2 Epidemiology and history
Epidemiological data on CFS are confusingly non-consistent. This is partly explained
by the varying case-definitions. However, two US community-based surveys using the
CDC-definition found prevalences of 0.23 % and 0.42 % (198, 327), whereas a British
primary-care study, using the same case definition, found a prevalence of 2.6 % (438).
Incidences have been estimated as high as 0.18 % and 0.37 % (237, 327).
Less is known about the impact of different sociodemografic variables. Most studies
have reported the prevalence in women to be about 3 times higher than in men (318).
CFS is relatively rare in children younger than 10 years, whereas the vulnerability
seems to be much higher in adolescents 10-17 years. An Australian survey found a
prevalence of 5.5/100 000 and 48/100 000 in these two age groups, respectively (248),
whereas a British study indicates much higher numbers (125). CFS is often regarded as
a condition typical of industrialized communities and Caucasian ethnicity, paralleling
the attitudes towards neurasthenia in the 19th century (254). Recent epidemiological
surveys indicate that CFS is equally common among Blacks and Hispanics as among
Whites in the US, excluding race as an important, independent factor (47, 198). However,
the prevalence of fatigue syndromes seems to be higher in well-developed countries
than in underdeveloped (371), at least partially justifying the notion of CFS as a disease
of ‘modern civilization’. Still, a Chinese study recently reported a CFS prevalence of
6.4 % (456), whereas the prevalence of chronic fatigue (not CFS) among Indian women
was found to be as high as 12 % (302).
Historically, descriptions of febricula - a CFS-like condition - can be traced back to the
1750s (362). In a retrospective study of medical records, Jones and Wessely found
indications of CFS among British soldiers in the 1850s (200). The term neurasthenia
was first introduced by the neurologist George Beard and the psychiatrist E Van Deusen
in 1869 (435). The first recorded epidemic outbreak of a CFS like condition occurred
in 1934 in Los Angeles, USA, among health care professionals from several hospitals
(199). Similar outbreaks have been described later on; the most prominent in Akureyri,
Iceland (1948); Adelaide, Australia (1949); the Royal Free Hospital, London, UK (1954)
and Great Ormond Street Hospital, London, UK (1970). The term myalgic
encephalomyelitis originated from these events, but an infectious agent was never
detected. Retrospectively, it is impossible to determine whether all or some of these
medical conditions correspond precisely to the modern definition of CFS.
1.1.3 Clinical features
As indicated in the name, fatigue is the dominating complaint in patients with CFS (2,
318). It is important to recognize this symptom as different from common tiredness or
sleepiness, experienced by everyone from time to time (Figure 1). The patients use
notions like ‘overwhelmingly exhausted’, ‘totally empty of energy’ etc., and they
12
describe the fatigue as qualitatively different from earlier experiences (178, 375). Limited
exertions, whether mental or physical, disproportionately worsen the sensation of fatigue.
Likewise, rest or sleep does not substantially relieve it.
In addition, the patients are to a varying extent bothered by additional symptoms, some
of which are required according to the CDC-definition (Table 2) (5, 123, 223, 318,
375). However, none of them are specific to CFS. As far as we know, no comprehensive
study has specifically addressed the frequency of each of these accompanying symptoms
in a large cohort of CFS patients. In a majority of patients, the symptom intensity is
fairly stable, but some report distinct fluctuations (128).
The onset of CFS can be gradual or acute (123, 318). In the latter situation, the patients
often report symptoms and signs indicative of a preceding infectious disease, like
mononucleosis, influenza or gastroenteritis (20, 345). However, despite intensive
research, no infectious agent seems to be specifically related to CFS. In addition,
evidence suggests that psychosocial stress might precipitate the disease in some patients
as well (180, 345). The relationship between these empirical findings and CFS
pathophysiology theories will be further elaborated below (see 1.3.2).
A diagnose of chronic fatigue syndrome requires a thorough clinical evaluation. No
single diagnostic test exists. Therefore, several guidelines have been developed, for
adults (1, 55, 417), as well as children/adolescents (123). Although not identical, the
main messages from these guidelines are common, prompting the practitioner to:
- Identify and recognize the patients’ characteristic symptoms, especially their
experience of fatigue.
Figure 1. Schematic outline of how CFS should be differentiated from well-defined
somatic and mental diseases as well as other subjective complaints (like common
tiredness and sleepiness). (Adapted from (100) and slightly modified, with permis-
sion.)
Common tiredness or sleepiness
Fatigue
Chronic fatigue syndrome (CFS)
Totally disabling
chronic fatigue
syndrome
Well defined somatic
diseases (e.g. multiple
sclerosis, post-polio
syndrome, cancer,
rheumatoid arthritis,
hypothyroidism)
Well defined psychiatric
diseases
(e.g. bipolar disorders)
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- Rule out differential diagnoses by a standardized and comprehensive (but not
exhaustive) set of investigations.
In addition, the practitioner should assess the patients’ functional impairments, which
might be severe, causing school and work absenteeism, social isolation and eventually
a breakdown of normal family life (318). A 4-stage functional classification system has
been proposed (1): Mild designates mobile patients, who are able to carry out e.g.
ordinary housework. Moderate means reduced mobility and limited ability to perform
daily activities. Severe labels patients who use a wheel-chair and whose performance is
restricted to some very simple activities, like teeth-brushing. Very severe is the category
for completely disabled patients, who are bedridden and not able to take care of personal
hygiene.
The question of co-morbidity in CFS has been extensively debated. Three problems
are of particular interest. First, the CDC-definition of CFS requires the exclusion of
somatic and/or psychiatric disorders that might explain the fatigue, like malignancies,
rheumatic diseases and chronic infections (142) (see 1.1.1). Whereas this prerequisite
Table 2. List of common accompanying symptoms in CFS, putatively 
organized according to organ systems 
Organ system Symptom 
Nervous system Headache 
 Dizziness 
 Problems with balance 
Increased sensitivity to light, sounds and smells 
Subjective temperature sensitivity  
Impairments of memory and concentration 
 Sleep disturbances 
Musculoskeletal system Muscle pain 
 Multi-joint pain 
Circulatory system Orthostatic intolerance 
 Palpitations 
 Paleness 
Digestive system Abdominal pain 
 Diarrhoea 
 Nausea 
Immune system Tender lymph nodes 
 Sore throat 
 Night sweats 
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is usually unproblematic in a practical sense, some cases expose an inherent incon-
sistency of the case definition. For instance, should a retracted course of EBV-infection
be labelled ‘chronic mononucleosis’, ‘CFS’ or both? Second, there are several clinical
similarities between CFS and other so-called ‘functional somatic syndromes’, like
irritable bowel syndrome and fibromyalgia (17). This fact increases the diagnostic
challenges, as well as raises further fundamental concerns about the case definition.
Third, there are different views concerning the relationship between CFS and well-
defined psychiatric diagnoses. The evidence seems conflicting; for instance, some studies
report increased prevalence of depression among CFS patients (2, 207), children and
adolescents being particularly at risk (148), whereas findings in other studies dispute
such a relationship (316, 318). Despite all these challenges, recent evidence supports
the notion of CFS as a distinct diagnostic entity (63).
Qualitative research indicates that CFS patients might have problematic relationships
with doctors and other health care professionals, feeling unaccepted, marginalized and
not prioritized (286). Doctors, on the other hand, report helplessness and scepticism
confronted with a condition of undetermined nature (8). These findings underscore
how CFS raises fundamental social and ethical challenges within the doctor-patient-
relationship. Without neglecting the several complicated aspects of these issues, it seems
pertinent to emphasize the doctors’ obligation to pay attention to and acknowledge the
patients’ subjective experience of symptoms, despite the lack of objective signs.
1.1.4 Treatment and prognosis
Various treatments of CFS have been subjected to randomized controlled trials. However,
recent reviews conclude that only cognitive behavioral therapy (CBT) and graded
exercise therapy (GET) have a scientifically proven beneficial effect (10, 100, 114,
280, 315, 335, 443). Important components of CBT are explanation of patho-
physiological theories about CFS, challenging of fatigue-related cognitions and gradual
increase of physical activity (318). In this way, simply speaking, the patients learn to
acquire control over their symptoms. CBT is also of proven value among adolescents
with CFS (401). Its success, however, does not necessarily imply a ‘psychological’ or
‘mental’ etiology. GET exposes the patient to an individually adjusted and structured
exercise program (318). The aim is a gradual increase of activity level; thus GET might
be regarded as a component of CBT. If the patients experience the exercise to be too
strenuous, compliance falls. Thus, a very careful and gradual approach seems to be
most beneficial (100). How these principles of treatment relate to subgroups of CFS
patients remains a question of debate. It is important to note that the severely disabled
patients are scarcely represented in the trials.
Other therapeutic approaches that have been subjected to research include gluco-
corticoids, mineralcorticoids, antidepressants, anticholinergic agents, antiviral drugs,
growth hormone, immunoglobulins, dietary prescriptions and alternative/complementary
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therapy. For all, the present evidence is inconclusive or indicates no beneficial effect
(100).
Management of CFS patients should also include attention to possible complications,
like secondary depression and dietary deficiencies in the severely disabled. Further,
patients need appropriate assistance with social and economical issues, as problems
related to these areas may constitute important perpetuating factors (37, 352). In children
and adolescents with CFS, particular effort should be devoted to their situation at school,
establishing courses adjusted to the patients’ individual capacity (123).
The long term prognosis of CFS is disputed. A recent review reported a 5 % median
full recovery and 40 % median improvement across different primary studies (51). The
prognosis of children and adolescents with CFS seems to be considerably better, with
full or partial recovery in 60-80 % (21, 337).
1.2 Basic science starting point – an overview of the
autonomic nervous system
1.2.1 Structure and function of the autonomic nervous system
The autonomic nervous system (ANS) denotes those parts of the nervous system that
are related to involuntary and unconscious control of internal organs, in contrast to the
somatic nervous system which is devoted to conscious perception and voluntary action
(43, 155). Generally speaking, the purpose of ANS is to maintain internal homeostasis
by constantly adjusting organ function; at the tissue level, this regulatory task is carried
out through an effect on smooth muscles, heart muscles and glands.
The sensory part of ANS mediates information to the central nervous system from
receptors in the internal organs. These receptors have different properties; of particular
interest in regards to this thesis are the mechanical receptors located in the walls of
great veins/heart/pulmonary vessels and aorta/carotid arteries, commonly referred to
as cardiopulmonary receptors and baroreceptors, respectively. The effector part of
ANS consists of chains of two neurons which synapse in an autonomic ganglion; thus,
they are commonly labeled preganglionic and postganglionic (Figure 2). The transmitter
in the ganglia is acetylcholine, acting on nicotinic receptor proteins of the postganglionic
neuron.
Based upon both structural and functional characteristics, one can differentiate between
two branches of the effector part of ANS: the parasympathetic nervous system and the
sympathetic nervous system (43, 155, 353). The former innervates only the visceral
organs proper, whereas the latter also has contact with blood vessels all over the body,
as well as the skin and the musculoskeletal system (Table 3). Overall, the parasympathetic
16
Figure 2. Schematic overview of the autonomic nervous system (upper part), and
detailed outline of a noradrenergic sympathetic synapse (lower part, adapted and
modified from (155)). NE=norepinephrine, DOPA=dihydroxyphenylalanine,
DHPG=dihydroxyphenylglycol, MAO=monoamine oxidase, COMT=catechol-O-methyl-
transferase.
Brainstem
Thoracolumbar spinal cord
Sacral spinal cord
Preganglionic
parasympathetic neuron
Postganglionic
parasympathetic neuron
Ganglion 
Acetylcholine
Acetylcholine
Norepinephrine
Postganglionic
sympathetic neuron
Postganglionic
sympathetic neuron
Adrenal gland
Adrenomedullary cell
Chain of
sympathetic ganglia
Nicotinic receptor protein
Muscarinic receptor protein
Preganglionic
sympathetic neuron
Other brain
areas
Target cell
Adrenoceptor
Epinephrine
Depolarization of
cell membrane
DOPA
Dopamine
DHPG
DHPG
MAO
NE
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Uptake-1
Uptake-2
COMT
Normeta-
nephrine
Normetanephrine
Capillary
Tyrosine
Target cell
Different
second
messengers
and effects
_1_2
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Table 3. Main effects of autonomic nerve activity and epinephrine in 
different organs. Overview*  
Organ Parasympathetic 
nerve activity 
Sympathetic nerve 
activity 
Epinephrine 
Heart Decreased rate Increased rate 
Increased contractility 
Increased rate 
Increased 
contractility 
    
Kidney  Increased renin 
secretion 
Vasoconstriction 
Vasoconstriction 
    
Lungs Bronchoconstriction Bronchodilation Bronchodilation 
    
Liver  Increased 
glycogenolysis 
Increased 
glycogenolysis 
    
Adipose tissue   Increased lipolysis 
    
Gastrointestinal 
tract 
Increased motility 
and secretion 
Decreased motility 
and secretion 
Vasoconstriction 
Decreased motility 
and secretion 
Vasoconstriction 
    
Urinary bladder Detrusor muscle 
contraction 
Sphincter muscle 
contraction 
    
Genital organs Erection Ejaculation  
    
Eye Miosis 
Accommodation 
Tear secretion 
Mydriasis  
    
Skeletal muscles  Vasoconstriction 
Shivering 
Vasodilation 
Shivering 
    
Skin  Piloerection 
Sweating 
Vasoconstriction 
Vasoconstriction 
    
Lymphatic organs  Undetermined effects Undetermined effects 
    
Central nervous 
system 
  Improved 
concentration  
Enhanced emotional 
experiences 
    
* Adapted from (43, 155, 353) 
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nervous system is mainly responsible for conservative, vegetative processes, while the
sympathetic nervous system is particularly important for ‘emergency’-reactions when
internal homeostasis is threatened. Accordingly, parasympathetic and sympathetic
nervous activity often has reciprocal effects on organ functions. However, this general
rule greatly oversimplifies the complex and dynamic interactions between the two
divisions of ANS.
The preganglionic neurons of the parasympathetic nervous system originate in the nuclei
in the brain stem and the sacral spinal cord (Figure 2) (43, 155). Many of them follow
the vagus nerve; hence ‘vagal’ is commonly, though inaccurately, used as a synonym
for ‘parasympathetic’. The postganglionic neurons use acetylcholine as the main
transmitter, acting upon muscarinc receptor proteins of which there are several variants
related to different second messengers.
The preganglionic neurons of the sympathetic nervous system emanate from the
intermediolateral column of the thoracolumbar spinal cord, and end in the preaortic
and paravertebral chains of ganglia (Figure 2) (43, 155). Most postganglionic neurons
use norepinephrine (noradrenalin) as the main transmitter, but the neurons supplying
sweat glands use acetylcholine. In addition, other transmitter substances like ATP and
neuropeptide Y have been described but their physiological effects remain largely
unknown (109, 308). Norepinephrine is synthesized from the amino acid tyrosine;
intermediate products in this process are dihydroxyphenylalanine (DOPA) and dopamine
(Figure 2) (155). The transmitter is stored in synaptic vesicles and released by exocytosis
upon depolarization of the cell membrane. The receptor proteins binding to norepine-
phrine, commonly referred to as adrenoceptors, are divided into two main categories,
labeled alpha and beta. Numerous subtypes are described, having different functional
properties. Alpha2-adrenoceptors, which are found presynaptically at sympathetic
neurons and also in the central nervous system, are particularly important for negative
feedback-regulation, as the binding of norepinephrine to these proteins attenuates
sympathetic nervous activity. Released norepinephrine is inactivated by two different
uptake-mechanisms (Figure 2) (155). Uptake-1 designates transport by a specific
membrane protein back into sympathetic nerve terminals. Here, the transmitter might
be recycled into storage vesicles, or degraded by the enzyme monoamine oxidase (MAO)
to form dihydroxy-phenylglycol (DHPG). Uptake-2 means transport into non-neural
cells, and subsequent degradation is mainly performed by the enzyme catechol-O-
methyltransferase (COMT), forming normetanephrine.
The adrenal medulla closely resembles a sympathetic ganglion. The adrenomedullary
cells are controlled by preganglionic sympathetic neurons, and are thus themselves
analogue with postganglionic neurons (43, 155). However, they secrete epinephrine
(adrenalin) instead of norepinehrpine, and this chemical compound functions as a
hormone, not a neurotransmitter. Although epinephrine binds to both alpha- and beta-
adrenoceptors, the affinity differs from that of norepinephrine. This partly explains
why increased adrenomedullary activity and generally enhanced sympathetic nerve
activity does not produce identical physiological effects (Table 3). The main break-
down route of epinephrine is degradation by COMT to metanephrine.
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Specific areas in the central nervous system receive afferent impulses from receptors in
the internal organs and control efferent impulses in the effector part of ANS (Figure 3).
In addition, these areas communicate with other brain centers responsible for emotional
and cognitive processes, voluntary movements, conscious perception, and endocrine
control. For instance, an area in the reticular substance of the medulla oblongata (the
rostral ventrolateral medulla, RVLM) indirectly receives inputs from baroreceptors,
and directly controls preganglionic sympathetic neurons, thus constituting a vital part
of the baroreceptor reflex (se 1.2.2) (155). In addition, RVLM is reciprocally connected
with the nearby raphe nuclei, with locus ceruleus in pons, with the paraventricular
nucleus in hypothalamus, and with amygdala in the limbic system. The raphe nuclei
probably have a key role in processing painful stimuli (43). The neurons of locus ceruleus
Figure 3. Selected areas and connections within the central nervous system impor-
tant for autonomic control. The figure is greatly simplified. (Adapted and modified
from (43)).
Thalamus
Locus ceruleus
Raphe nuclei
Nucleus of the solitary tract
From baroreceptors and
cardiopulmonary receptors
AmygdalaPituitary gland
Hypothalamus
Paraventricular nucleus
To preganglionic sympathetic
neurons in spinal cord
Rostral ventrolateral medulla
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project extensively to all brain areas (160). Being part of the brain stem ‘activation
system’, the locus ceruleus probably participate in the regulation of sleep and conscious-
ness; in addition, this area seems to be important for attention (43). Neurons in the
paraventricular nucleus produce the hormones vasopressin and corticotropin-releasing
hormone (CRH), which are secreted by axons projecting to the pituitary gland. CRH
controls the synthesis of adrenocorticotropic hormone (ACTH), which in turn regulates
the secretion of glucocorticoids from the adrenal cortex. Amygdala probably has a key
role in emotional memory, relating sensory information to specific emotional states,
and orchestrating appropriate behavioral and autonomic responses (43). In other words,
amygdala seems to be important for various learning processes, in particular
conditioning.
1.2.2 Homeostatic regulatory systems
General considerations
Teleologically speaking, the main purpose of the autonomic nervous system is to
maintain short-time homeostasis (155). This is achieved through numerous control
circuits, whose common, basic structure is schematically outlined in Figure 4. In this
thesis, three of these regulatory systems are of particular interest, namely those
controlling arterial blood pressure, blood volume and body temperature.
The performance of all these reflex loops might be characterized by two variables: the
set-point, designating a theoretical objective for the continuous adjustment of the
controlled variable (like arterial blood pressure), and the sensitivity (or gain), referring
to the response of the effector organs when the controlled variable deviates from the
Figure 4. Schematic outline of a homeostatic control circuit involving the autonomic
nervous system.
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set-point (381). Both set-point and sensitivity might be altered in different physiological
and pathophysiological states. For instance, during exercise, the set-point of the baro-
receptor reflex is reset to a higher level, probably due to the combined effect of neural
inputs from higher brain centers (‘central command’) and from receptors in the working
muscle (269). In addition, there is a decrease of sensitivity which seems to be caused
by altering sympathetic and parasympathetic modulation of heart rate (292).
Most control circuits, whether in physiology or engineering, expose dynamic behavior,
characterized by the fluctuations of the controlled variable around a mean value
corresponding to the set-point (7, 73, 416). This variability may be explored by sophisti-
cated mathematical analyses, providing important information concerning the neural
control mechanisms, as will be further elaborated below (see 2.2.2).
Arterial blood pressure
The arterial blood pressure is continuously monitored by mechanical receptors – baro-
receptors - in the aorta and the two common carotid arteries (Figure 5) (113). The
afferent neural impulses are transmitted to the nucleus of the solitary tract in the brain
stem via the glossofaryngeal and vagus nerves, and further mediated to cardiovascular
control centers of the reticular substance and to other brain areas (see 1.2.1) (216, 381)
(Figure 3). Recent evidence indicates that even cortical brain regions are involved
(218).
The efferent part of the reflex loop has two ‘limbs’: sympathetic and parasympathetic
neurons to the heart adjust heart rate and contractility, whereas sympathetic neurons to
arterioles adjust total peripheral resistance (155). The relative contribution from the
Figure 5. Schematic outline of the baroreceptor reflex controlling arterial blood pressure.
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different vascular beds for increasing total peripheral resistance in distinct physiological
and pathophysiological states is still largely undetermined; however, skeletal muscle
vasoconstriction is usually considered the most important effector response (209, 353).
Whether the baroreceptor reflex participates in long-term regulation of blood pressure
is unknown. However, ample evidence indicates that baroreceptor resetting occurs
shortly after artificial manipulation of blood pressure, which raises questions concerning
their role in long term regulation (259, 294).
Blood volume
Blood volume is regulated by several complex control circuits, involving both neural
and endocrine mechanisms (Figure 6) (155, 353). Here, the focus is on the autonomic
nervous system. The cardiopulmonary receptors designate a diverse group of mechanical
receptors located in the central, low-pressure part of the circulatory system (172). Their
apparent role in circulatory homeostasis may justify the term ‘volume receptors’;
however, detailed knowledge of their anatomical and functional properties is still lacking.
Afferent discharge seems to follow the same route as afferent discharge from the arterial
baroreceptors (326). Still, the effector part of the reflex is not identical to the baroreceptor
reflex, as one of its important components is efferent sympathetic neurons to the kidneys
(155, 164). These neurons control both renal perfusion and the release of the hormone
renin. In addition, efferent sympathetic neurons to skeletal muscles adjust total peripheral
resistance by controlling arteriolar constriction (12), and supposedly also adjust total
blood vessel capacitance by controlling venous constriction. The participation of other
vascular beds in the control circuit remains uncertain, but adjustments of splanchnic
perfusion probably play an important role (186). Finally, efferent parasympathetic and
Figure 6. Schematic outline of the cardiopulmonary reflex controlling blood volume.
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sympathetic neurons adjust heart rate and contractility (144, 418). However, heart rate
control also differs from the baroreceptor reflex, as moderately augmented cardiac
filling may – in some situations – increase heart rate (the so-called ‘Bainbridge-reflex’)
(15). To increase complexity further, evidence indicates that the cardiopulmonary and
baroreceptor reflexes interact (430).
Body temperature
Discrete regions of the hypothalamus seem to be directly involved in human
thermoregulation, having specific populations of temperature-sensitive neurons (43,
155) (Figure 7). In addition, these areas receive sensory information from thermo-
receptors in the skin. A region in the posterior hypothalamus seems to be the principal
‘conductor’ orchestrating the physiological responses to heat or cold (105). Areas in
the brain stem, in particular the raphe nuclei, are probably involved in the efferent
pathways (54, 278). The effector organs involved with human thermoregulation are
sweat glands, skin arterioles, skin arteriovenous anastomoses and skeletal muscles.
Sweat glands are innervated by cholinergic sympathetic neurons, which also seem to
promote vasodilation in nearby arterioles by a local release of NO and prostaglandins
from the endothelial cells (210, 211). However, the main control of skin arterioles, and
also of skin arteriovenous anastomoses, is exerted by vasoconstrictive noradrenergic
sympathetic neurons (23). Skeletal muscles are controlled by motor neurons of the
somatic nervous system; however, enhanced sympathetic outflow and epinephrine
secretion promotes shivering (155, 391).
Several other features of human thermoregulation add to its complexity. First, central
and peripheral thermoreceptors may give rise to conflicting afferent information (353).
Figure 7. Schematic outline of the thermoregulatory reflex controlling body temperature.
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Second, local temperature changes may call for differentiated responses to distinct
parts of the body (23). Third, the thermoregulatory and cardiovascular control circuits
share effector organs – the skin blood vessels – causing ‘conflicts of interest’ during for
instance strenuous exercise (155). Fourth, thermoregulation also includes appropriate
behavioral responses, such as taking on or off clothes, as well as endocrine responses
from the adrenals and the thyroid gland adjusting energy metabolism (391).
1.3 The pathophysiology of chronic fatigue syndrome –
epistemological issues, prior findings and research questions
The approaching of a scientific problem is inevitably influenced by prior knowledge
and attitudes. There is – in other words – no true neutral position (147). A researcher is
always restricted by his ‘horizon of understanding’ even before he starts searching the
literature and formulating research questions. Therefore, in this section, I will start out
by discussing some fundamental epistemological issues and clarifying my positions in
regards to them. Thereafter I will present the body of knowledge concerning CFS
pathophysiology and the specific aims of this thesis.
1.3.1 Epistemological considerations and premises
Fatigue is poorly defined both linguistically and biologically, despite how common it
is in clinical practice (407). One attempt of classification is to differentiate between
‘central’ fatigue, originating from the central nervous system (CNS) and ‘peripheral’
fatigue, originating from peripheral nerves and muscles. However, the evidence
justifying such a theoretical construct seems sparse. Even the precise meaning of the
word ‘fatigue’ is obscure, a consequence of its completely subjective nature. Does it
describe identical experiences when used in relation to, e.g., CFS, liver disease and
marathon running, or is the sensation of ‘fatigue’ in these situations different (though
related), indicating separate biological mechanisms?
As fatigue is a subjective experience, it cannot be objectively measured. Several
psychometric instruments have been developed (108, 228). However, the lack of a
‘gold standard’ will always raise questions of validity, both in regards to the instruments
themselves, and the empirical research based upon them. Thus, from a very restrictive
point of view, one might argue that fatigue is not ‘researchable’ within the paradigm of
the natural sciences at all.
Recent theories of fatigue focus primarily on mechanisms within CNS. Evidence
indicates the important role of corticotropin-releasing hormone (CRH), some cytokines
(IL-1beta, IL-6), and the neurotransmitters serotonin (5-hydroxytryptamine), dopamine
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and norepinephrine (56, 250, 407). These mediators may be influenced from processes
– including diseases – outside the CNS, like chronic inflammatory conditions, but they
are also strongly related to nerve activity in limbic and cortical brain centers. Thus,
fatigue is dependent upon both ‘mental’ and ‘somatic’ processes, as can be demonstrated
empirically (97, 173).
Exploring mechanisms of causality is a general aim within the natural sciences (147).
However, given the complex nature of fatigue, cause-effect-relationships are difficult
to establish. For instance, is the increased serotonin concentration within CNS, which
has been reported in fatigued subjects (407), a cause or a consequence of fatigue?
Similar uncertainties apply to most interpretations of empirical findings within this
field. Further, the causes of fatigue can be multifactorial in each individual, and a 1:1-
relation between cause and effect seems both empirically and theoretically unlikely
(436).
The challenges described above in relation to fatigue in general, also apply to CFS
research. In addition, there is the problem of case definition, as mentioned in 1.1.1. No
firm evidence supports a specific relationship between certain accompanying symptoms
and pathophysiological mechanisms; thus, the symptom criteria in the CDC-definition
may seem somewhat arbitrary (31, 436). Among children and adolescents, the validity
of this definition is even less established (123, 265). On the other hand, grouping together
conditions that do have different etiology or pathophysiology, although we do not know
them yet, might obscure important scientific findings. As of now, this dilemma awaits
its solution.
In conclusion, research surrounding CFS pathophysiology is challenged by:
- The subjective nature of fatigue, including the problems of how to measure it.
- The limited knowledge concerning the biological mechanisms of fatigue,
including undetermined cause-effect-relationships, the possibility of multi-
factoriality, and the likelihood of body-mind-interaction.
- The uncertain validity of the CFS case definition, especially within the pediatric
population.
In this thesis, the positions taken towards these challenges are as follows. First, although
fatigue is a subjective experience, we maintain that it nevertheless constitutes a
phenomenon which merits systematical, scientific investigation. That fatigue – and
CFS – exists and constitutes a clinical entity is an assertion of high ‘face validity’,
supported by empirical findings (178, 405). Furthermore, scientific investigations in
this field should certainly include, but not be restricted to, the use of hermeneutic
methods. In our view, the relative absence of measurable entities does not exclude a
natural science approach a priori. Second, given the limited mechanistic knowledge,
investigations could hardly be governed by hypotheses of causality. Rather, the aim
must be phenomenologic: to explore and describe aspects of the pathophysiology, and
thereby – hopefully – be able to present hypotheses for further research. Third, the
complexity of the matter, and in particular the possibility of body-mind-interactions,
suggests that the results of the study should be interpreted within a biopsychosocial
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framework, despite its biological starting point (117). There is a widespread acceptance
that fatigue cannot be understood within a traditional, dichotomous, Cartesian-inspired
classification of medical phenomena as either ‘physical’ or ‘psychological’ (318, 436).
Fourth, the ambiguity of the CDC-definition, specifically emphasized in a recent,
authoritative review (63), suggests a modification of it. We therefore omitted the
bicriterion (4 of 8 accompanying symptoms, see 1.1.1), and included patients solely
based upon the fulfillment of the main criterion, as will be further outlined below (see
2.1.1).
1.3.2 Prior research on CFS pathophysiology
Prior research surrounding the pathophysiology of CFS has been conducted along several
tracks, reflecting the great uncertainty about the condition as well as the different
scientific traditions among the researchers. This has resulted in a vast amount of papers;
a PubMed search using ‘chronic fatigue syndrome and pathogenesis’ as criterion
generated more than 1600 hits. Still, there is at present no coherent theory, and CFS is
often labeled ‘mysterious’ or ‘controversial’ (155). In this brief review, all aspects of
the pathophysiology will be considered, but with an emphasis on research relating CFS
to the autonomic nervous system.
Genetics
Twin studies indicate a moderate heritability of CFS (63, 404). In a recent comprehensive
attempt to integrate clinical and epidemiological data with genomic and proteomic
profiles (429), findings suggest that chronic fatigue is related to polymorphisms of
genes involved in CNS control of autonomic and endocrine effector systems, including
the genes for monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT)
(154, 373). Further analyses of gene expressions in mononuclear blood cells revealed
very complex results, indicating altered activation of genes controlling both common
metabolic pathways (gluconeogenesis, lipid metabolism) and signal transduction
pathways involved in immune and neuroendocrine responses (124, 439). Other studies
have reported a similar complicated picture (215).
Infections
CFS often has an acute onset with symptoms strongly resembling an infection (see
1.1.3). Therefore, a substantial amount of research has tried to detect a possible infectious
agent. In the 1980s, much attention was given to the Epstein-Barr virus (EBV), as
infectious mononucleosis may have a prolonged course or – in the worst case – develop
into CFS (52, 441). However, no specific role of EBV has been established (226);
rather, an EBV-infection should be regarded as one of many possible precipitating and
eventually perpetuating factors (2). The same view applies to several other
microorganisms that may similarly elicit severe fatigue and a prolonged recovery in a
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subset of patients; examples include cytomegalovirus, parvovirus B19, Brucella-species,
Toxoplasma gondii, Coxiella burnetii, Mycyplasma-species and Chlamydia pneumoniae
(61, 62, 243, 284). However, it should also be noted that common, non-specific infections
(like upper respiratory tract infections) are not likely to trigger CFS (437).
A possible pathogenetic role of enteroviruses has been thoroughly debated. Using the
PCR technique, Gow and co-workers reported enteroviral RNA in skeletal muscle
biopsies in a majority of adult CFS patients; however, enteroviral RNA was also detected
among some controls (163). In a recent review, Chia concluded that enteroviruses might
have a pathogenetic role in CFS patients, possibly causing chronic inflammatory changes
in skeletal muscle (61).
Immunity
The significance of immune system disturbances in CFS patients has been a matter of
controversy. Based on a systematic review of studies addressing T-cell function, B-cell
function, NK-cell function, immunoglobulins and cytokines, Lyall and co-workers
concluded in that there is no consistent pattern of immunological abnormalities in CFS
patients, although they found a trend towards changes in T-cell activity (255). Recent
studies have reported a reduced level of the cytokine TGF-beta1, which normally inhibits
antibody production, increased levels of IL-6 (53), which stimulates the acute phase
response, and alterations in the 2-5A synthetase/ribonuclease L pathway (94, 403),
which participate in intracellular defense against viruses. The latter abnormality also
seems to correlate with exercise performance (289). More generally, there is evidence
of a bias towards Th2 immune responses (humoral) at the cost of Th1 immune responses
(cellular) in CFS (63, 301, 372). This is consistent with frequent reports of reduced NK
cell activity (2, 249), as these cells are important effectors in the Th1 immune reaction.
However, a twin study did not report significant differences between CFS patients and
their healthy siblings (344).
Studies of autoimmunity have yielded conflicting results. Recently, researchers reported
the presence of autoantibodies specifically directed against the muscarinic cholinergic
receptor protein (410) as well as autoantibodies against certain common cellular antigens
(428). An association between CFS and distinct HLA antigens has also been reported
(191).
Oxidative stress
One study found increased levels of methaemoglobin and other indicators of oxidative
stress, correlating strongly with the patients’ complaints (328). Similar findings have
later been reported by others, providing evidence of free radical attacks on cell membrane
phospholipids in CFS patients (212). These results could be explained by immune
activation in general, but could also be attributed to a persistent viral infection. Increased
oxidative stress has, in turn, been proposed as an explanation for altered skeletal muscle
excitability as well as muscle pain and postexertional malaise among CFS patients
(197).
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Skeletal muscle function
Several early studies concluded that CFS patients have perfectly normal muscle strength,
endurance and recovery, as reviewed in the Australian CFS guidelines (64). However,
others report that patients are weaker than sedentary controls as judged from maximum
voluntary contraction (143, 304), and that their performances are further attenuated 24
hours later, indicating delayed recovery (143). Neurophysiological experiments suggest
that one probable explanation is an altered activation of cortical motor areas in the
central nervous system of CFS patients; this phenomenon being even more pronounced
when the isometric exercise induced a subjective experience of fatigue (351, 367).
Related findings of altered cortical excitability are reported during non-fatiguing
movements (380), and also immediately prior to motor performances, the latter indicating
disturbances of attention (162). Interestingly, attention deficit has also been suggested
in an earlier neurophysiological study of different design (314), whereas altered planning
of motor activities is adherent with recent findings by functional magnetic resonance
imaging (91).
In 1991, Behan and co-workers reported intracellular lipid excess and morphological
changes of mitochondria in skeletal muscle biopsies from CFS patients; these findings
could perhaps be attributed to an intracellular infectious process, but are also similar to
alterations found in hereditary mitochondrial myopathies (19). However, these findings
were not reproduced (234, 312). On the contrary, it was concluded that despite inactivity,
skeletal muscle biopsies from CFS patients exhibit less fiber atrophy and related changes
than expected. A defect of oxidative metabolism and subsequent enhancement of
anaerobic glycolysis has been reported (447), but was not confirmed in recent research
(197). Still, Vecchiet and co-workers demonstrated increased pain sensitivity in skeletal
muscles and related morphological abnormalities (426). These findings may also explain
the altered activation of central motor areas due to negative feedback, especially since
exercise seems to lower pain threshold in CFS patients (442).
Neuroimaging
Neuroimaging studies in CFS patients have yielded conflicting results. Using brain
MRI, some investigators have reported subtle alterations of subcortical white matter,
correlating with the patients’ complaints (77) and a reduction in total gray matter volume
(90), whereas others did not find any differences between CFS patients and healthy
controls (80, 167). Functional MRI and SPECT techniques indicate an alteration in
information processing (90, 236), planning of motor activities (91), cortical perfusion
in general (457) and brain stem perfusion (83). However, a twin study indicated that
the resting regional blood flow pattern in the brain is similar between patients and their
healthy twins (244). A few PET scan studies have been undertaken in CFS patients.
Tirelli and co-workers documented glucose hypometabolism in the frontal cortex and
brain stem (414), whereas Siessmeier and co-workers found alterations of brain glucose
metabolism among half of the included patients, though no clear pattern could be defined
(368). Recently, two independent groups have reported a decreased number and/or
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affinity for the receptor protein 5-HT1A in hippocampus (70) and the serotonin transporter
protein in the cingulate gyrus (449). These results are in accordance with results
suggesting blunted serotonine activation of HPA axis (106), but contradict earlier
indications of increased serotonergic neurotransmission (69).
Sleep
CFS patients regularly complain of altered sleep patterns, in particular difficulties
initiating and maintaining sleep (224). Several researchers have provided evidence of
sleep disturbances in CFS (131, 261, 415), but no consistent pattern has emerged (2),
and some trials even failed to demonstrate any significant alterations in EEG signals
during sleep (13).
Cognitive function
Cognitive tests of CFS patients have revealed disturbances of memory, attention and
information processing, including those patients devoid of any psychiatric comorbidity
(93). Albeit the evidence is not uniform, a recent review concluded that CFS patients
do have modest, but significant, cognitive impairments (272). Some reports indicate
that cognitive performance deteriorates further during exercise (26, 232) but conflicting
results exist (78). Morris and co-workers exposed CFS patients to different mental and
bodily stressors, and reported an improved speed in planning tasks during concomitant
administrations of the alpha2-adrenoceptor agonist clonidine in high doses (277). There
are, however, also reports of a discrepancy between perceived and actual cognitive
performance among CFS patients (271), and twin studies showed that the healthy twins
had similarly reduced information processing abilities when compared to the CFS
patients (256).
Psychology and psychiatry
The possible relationships between CFS and psychiatric disorders have been – and still
are – matters of great controversy. Partly, this can be explained by the ambiguity inherent
in the different case definitions of CFS. Specifically, many CFS patients fulfill the
diagnostic criteria for a somatization disorder. However, whether such a diagnosis is
made «is, to a considerable degree, dependent on the examiner’s attributions of chronic
fatigue syndrome symptoms and is of limited use in understanding chronic fatigue
syndrome» (2). Also, the prevalence of panic disorders and generalized anxiety disorders
is much higher among CFS patients than within the general population, both among
adults (130, 235) and adolescents (149), suggesting related pathophysiologies. Finally,
depression is also common among CFS patients, but recent evidence confirms that
depression and CFS are two distinct entities (2, 63, 318, 422).
Although CFS often has an infection-like onset, research suggests that critical life events
(e.g. loss of spouse), severe physical stressors (trauma, surgery) and perceived chronic
difficulties – in particular those described as dilemmas - may precipitate the disorder
(180, 345, 412). Besides, some studies report that certain personality traits, like
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perfectionism and conscientiousness, predispose for CFS (319, 440), but evidence is
conflicting (448).
Psychological and social issues are often regarded as important perpetuating factors in
CFS (318). Certain illness perceptions, such as a poor sense of personal control over
symptoms and a strong focus on bodily sensations, are correlated to increased
impairments in several studies (182, 187, 310). Likewise, CFS patients express a fear
of physical exercise that does not correspond to their physical disability (288, 369),
they perceive their cognitive performance as poorer than it is in reality (271), and they
sleep better than what they subjectively report (13). Patients’ attributions also seem to
come into play, as a one-sided focus on somatic processes is related to a poorer outcome
(187).
These inappropriate cognitions may be strengthened by social interaction with family,
friends and health care professionals (318, 352). Reduced self-esteem is a common
complaint among adults (440) as well as adolescents (149), and a lack of social support,
which is often experienced by CFS patients, may further worsen the situation (317).
Finally, the social role of being ill is – despite obvious undesirable consequences - also
potentially rewarding, causing an unconscious cycle of reinforcement (318).
Endocrinology
The hypothalamus-pituitary-adrenal axis (HPA axis) has been extensively explored
among CFS patients, and there seems to be a general agreement concerning some subtle
alterations, although the results are far from uniform (63, 68, 299, 318). Most researchers
in this field report low basal levels of cortisol in urine, plasma and saliva as well as
enhanced negative feedback, possibly due to increased sensitivity or number of
glucocorticoid receptors in the brain (68); some recent studies, however, failed to
reproduce these findings (190, 208). The normal circadian rhythm of HPA activity is
also disturbed, particularly attenuating cortisol secretion during the morning hours (63,
95, 103, 415). As for challenge tests, most studies indicate blunted HPA axis responses
to exercise, hypoglycemia and the administration of stimulating pharmaceuticals (68,
295, 355); however, high doses of the alpha2-adrenoceptor agonist clonidine increase
plasma levels of cortisol under conditions of high arousal (277). The underlying
mechanisms for these disturbances as well as their functional consequences remain
unresolved; however, a relationship to the documented immune abnormalities is an
obvious possibility (63).
Several researchers have focused on other endocrine systems. There are some reports
of increased levels of dehydroepiandrostenedione (DHEA) (71), whereas others found
the opposite (68). Studies addressing endogenous opoid tone have also reported
conflicting results (68, 190). The GH and prolactin systems seem to be intact in CFS
patients (68, 103, 295), whereas melatonin levels appear to be higher than normal
(222).
Reports concerning catecholamines are sparse; existing evidence indicates increased
basal levels of epinephrine, but normal plasma levels of norepinephrine (208, 413).
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Compared with controls, CFS patients have lower plasma levels of tyrosine and higher
plasma levels of tryptophan after strenuous physical exercise, indicating disturbances
of the noradrenergic and serotoninergic transmitter systems in the CNS (150).
Demitrack and colleagues found reduced plasma levels of the norepinephrine breakdown
product 3-methoxy-4-hydroxyphenylglycol (MHPG) and increased levels of the
serotonine metabolite 5-hydroxyindoleacetic acid (5-HIAA), but the levels within
cerebrospinal fluid were similar to those found in the healthy controls (96). The
significance of this finding is unclear, as MHPG in plasma derives from many sources
(156).
Circulatory homeostasis
The first papers on cardiovascular disturbances in CFS patients emerged in the 1990s,
reporting neurally mediated hypotension during head-up tilt tests (35, 339).
Subsequently, variants of haemodynamic instability during orthostatic challenge – most
commonly neurally mediated hypotension or orthostatic tachycardia - have been
described by many researchers in adult as well as pediatric patients (231, 306, 340,
386, 387). Similar baseline abnormalities have also been reported (231), as well as a
relationship between symptom severity and a decline in stroke volume and baroreceptor
sensitivity during tilt (306, 307). More sophisticated analyses of cardiovascular
variability indicate a sympathetic predominance in the modulation of heart rate and
total peripheral resistance during rest, orthostatic challenge and moderate exercise (81,
92, 282, 370, 383). Recently, a shortened QT interval was reported among CFS patients,
further indicating increased sympathetic and attenuated parasympathetic cardiac
neurotransmission (283). A twin study, however, showed that CFS patients and their
healthy twins had similar haemodynamic responses to tilt-table testing (313), and a
recent population-based study failed to demonstrate orthostatic instability among CFS
patients (201), challenging the assumption that cardiovascular dysregulation is an
important aspect of CFS pathophysiology. Moreover, some studies of variability have
been inconclusive (390, 458) or simply negative (111, 453).
Hypovolemia has been proposed to underlie these regulatory disturbances, and was
indeed indicated in one study, although not to the level of statistical significance (126).
Accordingly, Streeten and co-workers provided evidence of reduced erythrocyte volume
(398) and impaired lower-limb venous innervation (396) in CFS patients, whereas Rowe
and colleagues found a strong association between CFS and the connective tissue disease
Ehlers-Danlos syndrome (338). Taken together, these results suggest that relative
hypovolemia might be a cause of hemodynamic disturbances in CFS. However, two
controlled trials of volume expansion treatment (fludrocortisone) in CFS were not
successful (309, 341).
Hemodynamic disturbances have also been documented in other organ systems. Brain
stem hypoperfusion was an early finding (83). A general reduction in cerebral blood
flow upon standing has been reported as well (409), but was not confirmed in subsequent
experiments (325), thus weakening a hypothesis of reduced brain perfusion as a direct
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cause of the fatigue sensation. McCully and co-workers found normal oxidative
metabolism in working skeletal muscle, but subtle alterations in blood flow after dynamic
exercise, possibly due to sympathetically induced vasoconstriction (267). Abnormal
dilatation of renal and other intraabdominal veins has also been reported (408). Finally,
there is evidence of altered skin circulation, as CFS patients are more sensitive to the
vasodilative effect of locally applied acetylcholine (203, 378).
Temperature homeostasis
Adolescents with CFS seem to have an altered circadian rhythm of core body temperature
(415). Two studies in adult patients, however, found normal circadian variation (175,
176). Pazderka-Robinson and colleagues reported increased skin temperature and lower
electrodermal activity among CFS patients; the latter indicating attenuated sweating
(305). There is also evidence of altered skin circulation, as outlined above (203, 378).
The autonomic nervous system
Pagani and co-workers were among the first to suggest a relationship between autonomic
dysfunction and unexplained chronic fatigue, based upon research on cardiovascular
variability (298). Subsequently, the same group put forward a hypothesis of autonomic
dysfunction in CFS, characterized by enhanced sympathetic activity at rest and reduced
responsiveness to excitatory stimuli (297). Freeman and Komaroff reached similar con-
clusions based upon thorough autonomic testing that indicated an increased sympathetic
control of cardiovascular variables at rest, but decreased sympathetic modulation of
the same variables during orthostatic challenge (137). They proposed postviral auto-
nomic neuropathy or cardiovascular deconditioning as possible underlying mechanisms
for the observations. The possible significance of autonomic disturbances and the need
for comprehensive research projects have been recognized in subsequent papers (151,
159, 282). However, a unifying theory relating autonomic dysfunction to other
pathophysiologic aspects of CFS is still lacking.
Concluding remarks
Based upon this review, the following concluding statements seem to be justified:
- There is a hereditary component in CFS.
- Several different infectious agents may precipitate the disorder, but there is no
specific relationship.
- There is a shift towards a Th2 immune response at the cost of a Th1 immune
response.
- There is increased oxidative stress.
- Muscle weakness can be explained by alteration in CNS; evidence concerning
distinct muscle pathology is uncertain.
- Neuroimaging studies indicate reduced perfusion and metabolism in some brain
areas, as well as alterations in serotoninergic neurotransmission.
- There are alterations of cognitive function, in particular memory, attention and
information processing.
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- Psychological stress may precipitate CFS, whereas certain personality traits
constitute predisposing factors.
- Diverse psychological and social mechanisms contribute to the perpetuation of
the disorder.
- The activity and responsiveness within the HPA axis is decreased.
- There are alterations of cardiovascular regulation, particularly during orthostatic
stress, indicating increased sympathetic neurotransmission; relative hypovolemia
may be an underlying mechanism.
- There are disturbances in skin circulation.
- Autonomic dysfunction might constitute an important aspect of CFS
pathophysiology.
1.3.3 Aims and research questions
As evident from the review above, the scientific knowledge concerning CFS
pathophysiology is regrettably non-coherent and bewildering. In other words, there is
a great need for a unifying theory, bringing together empirical results which seem
unrelated at first glance.
As outlined in 1.2, the autonomic nervous system possesses strong ‘integrative
properties’, not only controlling organ functions and internal homeostasis, but also
constituting an important substrate for body-mind-interactions. Thus, the reported
evidence of autonomic dysfunction seems to be a promising starting point when
searching for a unifying CFS theory. Consequently, the general aim of this thesis is to
further explore the putative role of autonomic dysfunction in CFS pathophysiology.
More specifically, we asked the following questions:
A. When comparing adolescent CFS patients with healthy controls, how is the
expression of symptoms indicative of altered cardiovascular and thermoregulatory
autonomic control?
B. During supine rest, when comparing adolescent CFS patients with healthy controls:
a. How is the autonomic modulation of cardiovascular variables?
b. What are the levels of catecholamines and metanephrines?
c. How is the autonomic modulation of thermoregulatory variables?
C. During orthostatic stress, when comparing adolescent CFS patients with healthy
controls:
a. How is the autonomic modulation of cardiovascular variables?
b. How is the autonomic modulation of cardiovascular variables when isometric
exercise is performed in addition?
D. During local cold stress, when comparing adolescent CFS patients with healthy
controls:
a. What are the levels of catecholamines and metanephrines?
b. How is the autonomic modulation of thermoregulatory variables?
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2 Material and methods
2.1 Material
2.1.1 CFS patients
In 2001, a 13-year old boy suffering from long-lasting fatigue was referred to the Dep.
of Pediatrics at Rikshospitalet-Radiumhospitalet Medical Centre (a national tertiary
referral hospital) (see paper I). The clinical experience gained during the management
of this patient and a couple of other related cases resulted in the establishment of the
present research project as well as an outpatient service for children and adolescents
suffering from unexplained, chronic fatigue. In the latter, the patients were examined
according to an extensive, pre-defined program (Table 4), as recommended in the
literature (123). The program was revised in 2005, and due to resource constraints, a
significant portion of it was from this point on delegated to the referring unit. Still, all
patients underwent a thorough assessment at the referral centre.
A diagnose of CFS was made if the fatigue had persisted for more than 3 months, and
if the tests did not reveal any somatic or psychiatric disease which could explain it.
Thus, we omitted the bicriteria in the CDC case definition and also required a shorter
duration of fatigue than is required of adults, complying with recent recommendations
(123, 136, 265) (see 1.1.1). Patients were consecutively asked to participate in the
research project if they otherwise fulfilled criteria as outlined in Table 5. Both patients
and their parents/next-of-kin received oral and written information about the purpose
and content of the experiments. Their right to withdraw at any time without risking
poorer medical care was specifically emphasized. A written consent was obtained before
inclusion. All participants received a payment of NOK 200.
Before revising the clinical examination program, 15 patients were enrolled, constituting
the basis for the analyses in paper IV and V. After the program was revised, another 14
patients were included. However, due to concurrent alterations in experimental protocols
(see 2.2.1), 2 patients from the first cohort had to be excluded from the analyses in
paper II and III. Thus, these papers are based upon 27 patients.
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Table 4. Routine examinations in children and adolescents suffering from 
unexplained chronic fatigue 
Pediatric clinical assessment 
Blood samples* 
 Full blood count 
 ESR/CRP 
 Electrolytes 
 Renal function test 
 Liver function test 
 Iron status 
 Glucose 
 Thyroid function test 
Antibodies towards EBV, CMV, Borrelia, Mycyplasma, Chlamydia 
 Autoantibodies/complement activity 
Urine samples* 
 Dipstick 
 Total protein 
 Catecholamine breakdown products 
Imaging 
 Chest X-ray 
Abdominal ultrasound 
 MRI of brain and spinal cord 
Cardiologic examinations 
 24-hours ECG recording 
 Exercise tolerance test (treadmill)†
 Echocardiography†
Miscellaneous 
 EEG 
 Psychiatric assessment‡
* Only the most important analyses in blood and urine are shown here 
† These tests were removed from the routine program after revisions in 2005. 
‡ Due to resource constraints, only approximately one half of the patients were offered extensive 
assessment from an experienced child psychiatrist affiliated with the Dep. of Pediatrics, 
Rikshospitalet-Radiumhospitalet Medical Centre. The rest of the patients were referred to 
psychiatric teams in their local communities.  
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2.1.2 Healthy controls
In the period between August 2003 – June 2005, schools in the Oslo/Bærum area were
asked to recruit healthy controls for the study. Four schools responded positively, and
specific classes were selected in order to achieve a similar age distribution among
patients and controls. These classes received both oral and written information, and
individuals then volunteered to participate. During the course of the study, the emerging
proportion of males vs. females among the patients was used as a guide for the
recruitment of volunteer controls, thus assuring a similar distribution of gender within
the two groups.
Prior to final inclusion, the volunteers and their parents/next-of-kin received additional
written information about the purpose and content of the experiments. Their right to
withdraw at any time was specifically emphasized. A written consent was obtained. All
participants received a payment of NOK 200.
In total, 57 healthy controls were included, constituting the basis for the analyses in
paper V. Paper IV builds upon 56 controls, as one had to be excluded due to experimental
failure. However, parts of the experimental protocol were altered during the study period,
as will be further outlined below (see 2.2.1). Therefore, some controls had to be excluded
from the analyses in paper II and III, and the total number in these papers is only 33.
Table 5. Criteria for inclusion and exclusion of participants 
Participants Inclusion criteria Exclusion criteria 
12-18 years of age 
> 3 months of chronic fatigue*
CFS patients 
Severe disability resulting 
from fatigue†
Well-defined somatic or 
psychiatric disease that might 
explain the fatigue 
12-18 years of age Any known chronic disease  Healthy 
controls  Regular use of pharmaceuticals 
(including contraceptive pills) 
   
* The patients included in paper IV and V had all been fatigued > 6 months. This was, therefore, 
stated as an inclusion criterion, thus adhering better to the CDC-definition. Likewise, in paper II 
and III, we reported inclusion based upon > 4 months of fatigue, as no patients had shorter 
disease duration.  
†
 ‘Severe disability’ usually implied school absenteeism more than once a week. However, some 
patients were able to follow normal school progression, but only if they desisted from all other 
social activities. These patients were considered equally disabled. 
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2.2 Methods
2.2.1 Experimental protocols
For each participant, all experiments were performed during a single day, according to
the program outlined in Table 6. During the course of the study, we alternately summoned
CFS patients and controls, in order to minimize the risk of systematic errors. One week
prior to the experiments, the participants were instructed not to drink beverages
containing alcohol or caffeine, not to take any drugs, and not to use tobacco products.
On the day of the experiments, they were supposed to have fasted overnight. Two light
meals, consisting of a maximum of 2 pieces of bread and 2 glasses of water/juice, were
offered at certain hours, as specified in Table 6.
Neuroendocrine responses to strong cooling of one hand
All participants were instructed to apply an ointment containing the local anesthetic
lidocaine (Emla®) on the skin of the antecubital fossa one hour prior to arrival in the
morning. They rested supine for about 15 minutes, and a catheter was then placed in an
antecubital vein (Figure 8). After supine rest for another 15 minutes, blood samples
were collected on ice-cold vacutainer tubes containing gluthation-EGTA and heparin
for measurements of plasma catecholamines (norepinephrine, epinephrine, dopamine)
Table 6. Overview of experimental day 
Time Experiment/Activity Reported in paper
07.30 am Check in  
08.00 am Neuroendocrine responses to strong cooling of 
one hand 
IV, V 
08.45 am Light meal 
09.00 am Questionnaire II, IV, V 
09.30 am Head-up tilt-test (HUT) II, III 
11.00 am Valsalva-maneuver Not reported 
11.30 am Lower body negative pressure (LBNP) with 
handgrip 
IV
01.00 pm Light meal 
01.30 pm Cardiovascular responses to mental exercise Not reported 
01.45 pm Cardiovascular responses to moderate cooling 
of one hand 
V
03.30 pm End of experiments 
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and metanephrines (normetanephrine, metanephrine, 3-methoxytyramine), respectively.
The opposite hand was then immersed in cold water (10 oC) for 2 minutes, after which
new blood samples were collected immediately. Samples were then centrifuged at 4
oC, and plasma was separated for storage at –80 oC until assayed.
Metanephrines were extracted from the plasma using solid-phase ion exchange columns
(Bond Elute-Accucat, Varian Medical Systems, California, USA) and a commercial
mobile phase (Chromsystems, München, Germany) (240). Both catecholamines and
metanephrines were quantified by high performance liquid-chromatography with a
reverse phase column and glassy carbon electrochemical detector (Agilent Technologies,
Colorado, USA). The intra- and interassays variations were 10.7 % and 14.5 % for
norepinephrine, 23.5 % and 10.5 % for epinephrine, 7.2 % and 6.8 % for dopamine,
12.6 % and 4.3 % for normetanephrine, 11.7 % and 3.0 % for metanephrine, and 15.3
% and 11.2 % for 3-methoxytyramine.
Additional endocrine analyses were also carried out, including cardiac peptides, sex
hormones, renin, aldosteron, HPA axis hormones, vasopressin and insulin. The results
are not reported in this thesis.
Questionnaire
A questionnaire was developed based upon the translation of the Autonomic Symptom
Profile, a validated instrument for assessing orthostatic intolerance and other variants
of autonomic dysfunction (402). Some items were slightly modified in order to fit our
particular age group. Furthermore, the questionannire included a translated an slightly
modified version of the Fatigue Severity Scale (228), as well as questions focusing on
functional consequences of CFS based upon personal clinical experience with patients.
Finally, we added questions related to the CDC case definition and to demographic
characteristics. The subjects answered the questions during an interview. Only some
results from this extensive questionnaire are reported in this thesis.
During the course of the study, the questionnaire was slightly revised based upon personal
experience of its feasibility. Thus, a few items were not answered by all participants.
Time (min)
40 45 50 55 60 65 70 7515 20 25 30 350 5 10
Application of
anesthetic ointment
Supine rest 
Insertion of
intravenous catheter
Blood samples
for baseline values 
Blood samples
for post-cooling values 
Supine rest Immersion of onehand in water (10 0C)
Figure 8. Neuroendocrine responses to strong cooling of one hand: schematic outline
of the experiment.
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Head-up tilt-test
Conventional procedures of head-up tilt-test (HUT) involve tilting to 60o-80o for 30-45
minutes (22). Heart rate (HR) is usually continuously recorded from the electro-
cardiogram (ECG), whereas arterial blood pressure is measured at predefined intervals
(eg. every second minute) using ausculatory or oscillometric techniques. Thus, the
hemodynamic recordings are not very accurate. Correspondingly, the test focuses on
‘hard’ endpoints, such as syncope or near-syncopal events. However, the tolerance for
orthostatic stress is lower in adolescents than in children and adults (347, 444), and
conventional HUTs are burdened by a high rate of false positive results in this age
group, making the test less informative (89).
Our first HUT protocol implied 30 minutes of 60o tilt, and was performed in 2 CFS
patients and 22 healthy controls. Of these participants, 2 patients (100 %) and 9 controls
(41 %) experienced a syncope or a near-syncopal event (defined as more than 10 mm
Hg fall in either systolic or diastolic blood pressure, combined with orthostatic
symptoms). Faced with these results, we considered the protocol to be both uninformative
and possibly unethical, and therefore decided to revise it.
In the revised HUT protocol, which was successfully undertaken by 27 CFS patients
and 33 healthy controls, the subjects lay supine on an electronically operated tilt table
with foot-board support (Model 900-00, CNSystems Medizintechnik, Graz, Austria).
They were attached to the Task Force Monitor® (Model 3040i, CNSystems
Medizintechnik, Graz, Austria); a combined hardware and software device for non-
invasive recording of cardiovascular variables (133, 166). A 5 minute baseline recording
was obtained. Subjects were then head-up tilted 20o over approximately 10 seconds
(Figure 9). They were remained at 20o for 15 minutes, and then tilted back to horizontal
position after which the recording was continued for another 5 minutes, making the
total experimental period 25 minutes. Subjects were asked not to speak or move during
the recording period.
Instantaneous HR was obtained from the R-R interval of the ECG.
Photoplethysmography on the right middle finger was used to obtain a non-invasive,
continuous recording of arterial blood pressure. This method correlates satisfactorily
with invasive pressure measurements (300), and has also been validated in adolescents
Time (min)
16 18 20 22 24 26 28 306 8 10 12 140 2 4
20o  tilted position Supine rest 
Tilt downTilt up
Supine rest 
Figure 9. Head-up tilt-test (revised protocol): schematic outline of the experiment.
41
and children (356). Approximately every minute, the recorded value was calibrated
against conventional oscillometric measurement of arterial blood pressure on the
subjects’ left arm. The method of impedance cardiography, in which a small electrical
potential is applied between electrodes placed on the neck and upper abdomen, was
used to obtain a continuous recording of the temporal derivate of the transthoracic
impedance (dZ/dt) (98). All recorded signals were transferred online to the built-in
recording computer of the Task Force Monitor®, running software for real-time data
acquisition.
Lower body negative pressure with handgrip
The technique of lower body negative pressure (LBNP) is a well-established tool for
studies of cardiovascular adjustments during orthostatic stress (382), whereas handgrip
is a common test for studies of cardiovascular adjustments during isometric exercise
(161, 205). In our laboratory, we have developed a combined experimental set-up in
order to study complex regulatory adjustments (184).
The participants lay supine with their lower body in a plastic chamber, in which air
could be evacuated very rapidly, thus reaching a pre-defined negative pressure within
milliseconds (185). In order to prevent air leak, rubber devices were used to make a
tight seal around the subjects’ waist. They were lightly dressed, and the ambient
temperature was kept between 23 and 26 °C. They were familiarized with the test
procedure in two pilot experiments. By means of an electronic device (AB-detector,
Gøteborg, Sweden), the force of the subjects’ left-sided handgrip was continuously
displayed to them. They were first asked to perform maximum isometric work for
about 10 seconds. Based on the mean value, the 30 % level was calculated, and they
were then asked to use a couple of minutes to become familiar with this amount of
force.
Five minutes were used for baseline registration of cardiovascular variables (Figure
10). Then, LBNP of –20 mm Hg was applied instantaneously. After 6 minutes of LBNP,
the subjects were asked to perform left-sided handgrip with 30 % of maximum force
Time (min)
8 9 10 11 12 13 14 15 16 173 4 5 6 70 1 2
LBNP-20 mm HgSupine rest Supinerest
LBNP on
Handgrip, 30 %
of maximal force LBNP off
Figure 10. Lower body negative pressure with handgrip: schematic outline of the
experiment.
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Instantaneous HR was obtained from the ECG. Photoplethysmography on the right
middle finger was used to obtain a non-invasive, continuous recording of arterial blood
pressure (2300 Finapres, Ohmeda, Madison, WI, US) (300, 356). A continuous recording
of maximum blood flow velocity in the ascending aorta was obtained by a bidirectional
ultrasound Doppler velocimeter (SD-100, GE Vingmed Ultrasound, Horten, Norway),
operating in pulsed mode at 2 MHz (119). Using a handheld transducer, the ultrasound
beam was directed from the suprasternal notch towards the aortic root. The sample
volume range was adjusted so that measurements were made 1-2 cm above the aortic
valve. A continuous recording of mean blood flow velocity in the right brachial artery
(BABF) was obtained by another bidirectional ultrasound Doppler velocimeter (SD-
50, GE Vingmed Ultrasound, Horten, Norway), operating in pulsed mode at 10 MHz
(251). A continuous recording of acral skin laser flux, which is a measure of acral skin
blood flow (ASBF), was obtained by a laser-Doppler instrument (DRT4, Moore
instruments, Milway, Devon, UK), with the probe firmly attached with adhesive strips
to the pulp of the right index finger (24). The BABF and ASBF results are not reported
in this thesis. All recorded signals, including the pressure in the LBNP-chamber and
the force of the handgrip, were transferred online to a recording computer running a
program for real-time data acquisition (developed by Morten Eriksen, Dep. of Physi-
ology, University of Oslo, Oslo, Norway).
Cardiovascular responses to moderate cooling of one hand
In our laboratory, the general design of this experiment has been used in several other
studies concerning normal physiology (23). The participants were lightly dressed and
lay supine in a climatic chamber. Ambient temperature was maintained around 26 oC,
assuring that subjects were within their thermoneutral zone. The left hand was immersed
in a stirred thermostat-controlled water bath (CB 29-20e, Heto-Holtan, Åbyhøj, Den-
mark) with a temperature of 35 oC. 30 minutes were used for acclimatization and another
5 minutes for baseline registration, after which the water temperature was gradually
lowered to 19 oC over approximately 50 minutes (Figure 11).
A continuous recording of acral skin laser flux, which is a measure of acral skin blood
flow (ASBF), was obtained by a laser-Doppler instrument (DRT4, Moore instruments,
Milway, Devon, UK) (24). The probes were firmly attached with adhesive strips to the
pulp of the flexor surface of the distal phalanges of the right and left index fingers. In
this position, the probes mainly detect blood flow in arteriovenous anastomoses (23).
Tympanic temperature (TT) was continuously monitored by an electronic probe (D-
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Time (min)
40 45 50 55 60 65 70 75 80 85 9015 20 25 30 350 5 10
Gradual lowering of water temperature to 19 oCImmersion of left hand in 35 oC water 
Acclimatization Baseline registration
Figure 11. Cardiovascular responses to moderate cooling of one hand: schematic
outline of the experiment.
TM1, Exacon, Roskilde, Denmark) inserted in the outer auditory canal and isolated
from the ambient air by a piece of cotton. TT corresponds well with core body
temperature (331). Instantaneous heart rate (HR) was obtained from the ECG, whereas
photoplethysmography on the right middle finger was used to obtain a non-invasive,
continuous recording of arterial blood pressure (2300 Finapres, Ohmeda, Madison,
WI, US) (300, 356). All recorded signals, including the temperature of the water bath,
were transferred online to a recording computer running a program for real-time data
acquisition (developed by Morten Eriksen, Dep. of Physiology, University of Oslo,
Oslo, Norway).
2.2.2 Data analyses
Conventional cardiovascular variables
In all experiments using photoplethysmographic registration of blood pressure, the
beat-to-beat mean arterial pressure (MAP) was calculated by numerical integration of
the recorded continuous blood pressure signal within subsequent RR-intervals.
Accordingly, beat-to-beat systolic blood pressure (SBP) and diastolic blood pressure
(DBP) were taken as the highest and lowest value, respectively, of the recorded
continuous blood pressure signal within subsequent RR-intervals.
In the HUT experiment, beat-to-beat stroke volume (SV) was calculated from the
impedance signal (133). This method has been validated both in adults (98, 342) and
children (38, 343). In the LBNP experiments, beat-to-beat SV was calculated by
multiplying the value obtained by numerical integration of the recorded instantaneous
maximal blood flow velocity in the ascending aorta during each R-R interval by the
area of the aortic valve orifice. This area was determined by 2D ultrasound imaging in
a separate session. This method has been validated in adults (119), but not in children.
Cardiac output (CO) was calculated as SV times HR. Total peripheral resistance (TPR)
was calculated as MAP divided by CO. Furthermore, in the HUT experiments, the
impedance signal was used to estimate the beat-to-beat end diastolic volume of the left
ventricle (EDV), based upon the calculation of SV and ejection fraction (263), and
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acceleration index (ACI), defined as the highest positive slope of the impedance signal
(d2Z/dt2 max). ACI corresponds to the maximal acceleration of blood flow during the
ejection phase, and is regarded as an indirect marker of cardiac contractility (213).
All variables based upon volume measurements, i.e. CO, SV, TPR and EDV, were
normalized according to body surface area (BSA), using the following formula: BSA =
0.00235 x (height in cm)0.423 x (weight in kg)0.515.
Heart rate and blood pressure variability
Spontaneous variability is a characteristic feature of all cardiovascular variables, as
described above (see 1.2.2), reflecting the «homeodynamic interplay between
perturbations to cardiovascular function and the dynamic responses of the cardiovascular
regulatory systems» (7). Analyses of variability might be performed in the time domain,
where the extent of variability within a recording of certain length is expressed using
common statistical terms (411). For instance, when analyzing variability of RR-intervals
(inverse HR) in an ECG recording, SDNN is the standard deviation of all RR-intervals,
RMSSD is the square root of the mean square differences of successive RR-intervals,
and pNN50 is the proportion of successive RR-intervals with a difference greater than
50 ms.
Alternatively, analyses might be carried out in the frequency domain, in which the
signals are regarded as a mixture of sine waves of different amplitudes and frequencies
(7). This spectral analysis approach requires more sophisticated mathematical proce-
dures; the most common can be classified as either non-parametric methods (e.g. Fast
Fourier Transform) or parametric methods (e.g. Autoregressive modelling) (57, 73). In
any case, the extent of variability is expressed as the power of different frequencies.
Spectral analyses of short-time recordings of heart rate or blood pressure usually reveal
three distinct peaks in the power spectrum (411). By convention, spectral power densities
are computed in three frequency bands corresponding to these peaks, assigned very
low frequency (VLF, <0.04 Hz), low frequency (LF, 0.04-0.15 Hz) and high frequency
(HF, 0.15-0.4 Hz), respectively.
The RR-interval power spectral density in the HF-band might be considered an index
of the parasympathetic modulation of heart rate, whereas RR-interval power spectral
density in the LF region is due to the combined effect of cardiac parasympathetic and
sympathetic activity (73, 346). The LF/HF-ratio has often been regarded as a measure
of ‘sympathovagal balance’ in the modulation of HR, particularly during orthostatic
stress (112, 296). Blood pressure variability in the LF band (also known as Mayer
waves) is primarily a consequence of variations in efferent sympathetic neural activity
to peripheral resistance vessels, whereas blood pressure variability in the HF band is
due to a combination of the mechanical influence of ventilation and the effects of heart
rate variability on blood pressure (73, 258).
In this thesis, variability analyses were performed on the HR and DBP recordings from
the HUT experiments, using an adaptive autoregressive algorithm (see paper III) (132).
This technique yields a time-varying spectrum in which spectral power densities are
45
computed from consecutive segments of the biosignals (16, 57). The lengths of these
segments vary, as the biosignals are continuously monitored for departure from
stationarity, and the segment boundaries are placed accordingly. This approach is
advantageous in a situation where the variability is supposed to change as the
consequence of an intervention, e.g. the transition from supine to tilted position.
Mathematical processing of beat-to-beat recordings
Plots of the beat-to-beat recorded cardiovascular variables were inspected for each
participant. Obvious artifacts, e.g. due to temporary instrumental failure, were removed
and replaced by linear interpolation between values appraised to be valid. For the main
analyses in paper II-V, the median values within defined time periods of each recording
were computed, thus reducing the influence of possible false outliers even more.
In addition, in paper II-IV, the beat-to-beat recordings were converted to 4 Hz time
series of equal length by linear interpolation. These time series were filtered by assigning
the median value within a sliding window to each time point, thus removing both
minor artifacts and stochastic variability. Furthermore, all time series were normalized,
taking the mean value of the first time period as zero. Coherent averaging was then
performed by calculating the arithmetical mean for each time point (333).
In paper V, the beat-to-beat recordings of ASBF Left were searched for vasoconstrictor
events, defined to occur at the water temperature where the median value computed
over 30 consecutive heart beats was permanently less than 50 % of the median value
prior to cooling.
Statistical analyses
In all experiments, data plots were routinely inspected to assess their empirical
distribution. If approximating normality, the mean was taken as an estimate of the
expectancy of the population under study, and 95 % confidence intervals for the mean
was calculated according to parametric methods (see paper II and IV). If the empirical
distribution of data deviated from normality, the median and non-parametric 95 %
confidence intervals were used for the same purposes (see paper III and V).
In all experiments, non-parametric statistical test were regarded as most ‘robust’, and
therefore used to explore the differences between the two groups of participants (188).
In order to reduce the methodological problem of performing multiple statistical
comparisons, we reserved the statistical tests for variables that were considered most
central to our research questions. Generally, a p < 0.05 was considered statistically
significant.
2.2.3 Ethical and legal considerations
The principle of informed consent is considered vital in all research involving human
beings (121). Complying with this principle requires that the participants are fully
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informed about all aspects of the experiments, including any possible side-effects, and
that they are able to make a totally independent decision concerning whether or not to
participate. Therefore prior to inclusion, both patients and controls received thorough
information about the experiment orally and in written form.
In practice, and particularly when children are involved, the ideal of informed consent
are impossible to achieve (229). First, being ‘fully informed’ is, at least theoretically,
an endless task; in addition, there are no means to assess whether the information has
been perceived correctly by each participant. Second, no process of decision is totally
free of obligations; furthermore, children are not considered fully competent of making
decisions about their own life.
These obstacles were partly overcome by providing thorough information and requiring
a written statement of consent from the participants’ parents/next-of-kin. Still, we
maintain that medical research should also adhere to the principle of primum non nocere
(374). In other words, experiments on humans - and children in particular - cannot be
justified solely by the participants’ free, informed decision if the experiments impose
too great a risk of harmful effects.
Prior to the experimental phase of this study, none of the experiments were considered
to carry any element of risk. However, the following parts were addressed as potentially
unpleasant: pain during insertion of intravenous catheter and immersion of hand in
cold water, and dizziness or near-syncope during HUT and LBNP. If near-syncope
occurred, the protocols demanded the immediate termination of the experiment, in
order to minimize the risk of manifest syncope.
Our initial HUT protocol resulted in a high incidence of near-syncope and even syncope,
and was therefore abandoned as described above (see 2.2.1). During the revised
experiment, one CFS patient complained of unpleasant dizziness; however, near-syncope
or syncope was never observed. LBNP precipitated a harmless cardiac arrhythmia in a
healthy control; the experiment was terminated immediately, and the participant was
referred to an ordinary cardiologic assessment. Two other subjects (one CFS patient,
one control) reported dizziness or other unpleasant experiences during LBNP. The use
of anesthetic ointment seemed effective in reducing the pain related to catheter insertion.
The study was approved by the Regional committee for ethics in medical research and
the Norwegian Data inspectorate. The authors of the papers are all qualified according
to the Vancouver guidelines. None of them possesses any conflicts of interest related to
the subject matter of this thesis.
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3 Results
3.1 Subjects
27 CFS patients and 33 healthy controls were included in the experiments reported in
paper II and III, whereas 15 CFS patients and, respectively, 56 and 57 healthy controls
were included in paper IV and V (Table 7). In all experiments, the two groups had a
comparable distribution of gender, age, weight, height, and body surface area. All
participants, except one control, were of Caucasian ethnicity. The CFS patients were
sedentary, had a high Fatigue severity scale sum score, and reported a substantial amount
of functional impairment; however, no one was permanently bedridden. About 60 % fit
the CDC case definition of CFS.
3.2 Experimental results
The following research questions were presented in 1.3.3:
A. When comparing adolescent CFS patients with healthy controls, how is the
expression of symptoms indicative of altered cardiovascular and thermoregulatory
autonomic control?
B. During supine rest, when comparing adolescent CFS patients with healthy controls:
a. How is the autonomic modulation of cardiovascular variables?
b. What are the levels of catecholamines and metanephrines?
c. How is the autonomic modulation of thermoregulatory variables?
C. During orthostatic stress, when comparing adolescent CFS patients with healthy
controls:
a. How is the autonomic modulation of cardiovascular variables?
b. How is the autonomic modulation of cardiovascular variables when isometric
exercise is performed in addition?
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Table 7. Subject characteristics 
Variable Paper II and III Paper IV and V 
Control CFS Control* CFS
Number 33  27 57 15
Female gender 19 (58 %) 18 (68 %) 34 (60 %) 10 (67 %) 
Adherence to the CDC-criteria 15 (56 %) 9 (60 %) 
School absenteeism once a 
week or more†
0 (0 %) 23 (85 %) 0 (0 %) 10 (77 %) 
Not able to attend leisure 
activities once a week or 
more†
0 (0 %) 24 (96 %) 0 (0 %) 13 (100 %)
Permanently bedridden  0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %) 
Mean 
(range) 
Mean 
(range) 
Mean 
(range) 
Mean 
(range) 
Age (years) 15 15 16 15
(13-18) (13-18) (13-18) (12-18) 
Weight (kg) 61 56 62 59
(44-77) (37-92) (44-99) (43-92) 
Height (cm) 172 169 172 171
(149-195) (145-197) (149-195) (160-192) 
Body surface area (m2)  1.7 1.6 1.7 1.7 
(1.4-2.0) (1.3-2.3) (1.4-2.2) (1.4-2.2) 
Duration of fatigue (months)    30 31
(4-132) (6-60) 
Fatigue severity scale, sum 
score‡
1.5 
(1.0-2.3) 
4.5 
(2.9-5.0) 
1.5 
(1.0-3.6) 
4.6 
(3.8-5.0) 
Reported physical exercise 
(hours/week)  
6.7 
(2-14) 
0.5 
(0-6) 
6.2 
(1-20) 
0.7 
(0-7) 
        
* One female control included in paper V did not participate in the experiments of paper IV, due to 
the precipitation of cardiac arrhythmia during LBNP (see 2.2.3). Thus, in paper IV, some of the 
values (e.g. the numbers of female participants) deviate slightly from what is presented here.  
† Due to revisions in the questionnaire (see 2.2.1), these items were not answered by all 
participants, influencing the calculated percentage.  
‡
 The fatigue severity scale was slightly modified from the original publication, using a 1-5 Likert 
response scale for each item (228). 
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D. During local cold stress, when comparing adolescent CFS patients with healthy
controls:
a. What are the levels of catecholamines and metanephrines?
b. How is the autonomic modulation of thermoregulatory variables?
Below, the results of the experiments are summarized in accordance with these questions
3.2.1 Symptoms of altered cardiovascular and thermoregulatory autonomic control
Palpitations, dizziness, skin flushing, pale skin and an increased tendency to sweat
were prominent symptoms in the patient described in paper I. Table 8 summarizes the
questionnaire results reported in paper II, IV and V. As for cardiovascular autonomic
control, there is evidence that CFS patients more frequently than controls feel dizzy
Table 8. Symptoms of altered cardiovascular and thermoregulatory 
autonomic control – summary of results comparing CFS patients to healthy 
controls
Variables Questionnaire 
Cardiovascular autonomic control 
Experience fainting when rising quickly (Ĺ)
Feeling dizzy just after a heavy meal (Ĺ)
Feeling dizzy after standing upright for a long period Ĺ
Feeling dizzy during moderate physical exercise Ĺ
Feeling dizzy taking a hot bath or shower Ĺ
Thermoregulatory autonomic control
Experience sudden changes in skin colour Ĺ
- Sudden redness of skin Ļ
- Sudden paleness of skin Ĺ
Experience shivering hands Ĺ
Sweating more than others Ĺ
Feeling unusually warm after standing upright for a long period Ĺ
Feeling unusually warm after moderate physical exercise Ĺ
Feeling unusually warm after a hot bath or shower  (Ĺ)
Arrow=significant difference, direction indicating how CFS patients deviate from controls.  Arrow in 
parentheses=non-significant tendency.  
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Table 9. Cardiovascular, neuroendocrine and thermoregulatory variables 
during supine rest – summary of results comparing CFS patients to healthy 
controls 
Variables Prior to 
HUT
Prior to 
LBNP
Prior to 
strong 
cooling 
Prior to 
moderate 
cooling 
Cardiovascular variables     
HR (Ĺ) Ĺ Ĺ
SBP n.d. n.d.
MBP n.d. Ĺ  (Ĺ)
DBP n.d. Ĺ   
SI Ļ (Ļ)   
TPRI Ĺ n.d.   
EDVI Ļ    
ACI (Ļ)    
HRV, LFnorm n.d.    
HRV, HFnorm n.d.    
HRV, LF/HF n.d.  
HRV, time indices n.d.  
DBPV, LFnorm n.d.    
DBPV, HFnorm n.d.    
Neuroendocrine variables 
    
Plasma norepinephrine Ĺ
Plasma epinephrine Ĺ
Plasma dopamine  n.d.  
Plasma metanephrines  n.d. 
Thermoregulatory variables     
TT  Ĺ
ASBF Left (Ļ)
ASBF Right (Ļ)
Arrow=significant difference, direction indicating how CFS patients deviate from controls.  Arrow in 
parentheses=non-significant tendency. n.d.=no difference. HR=heart rate, SBP=systolic blood 
pressure, MBP=mean arterial blood pressure, DBP=diastolic blood pressure, SI=stroke index, 
TPRI=total peripheral resistance index, EDVI=end diastolic volume index, ACI=acceleration index, 
HRV=heart rate variability, LFnorm=low frequency, normalized units, HFnorm=high frequency, 
normalized units, DBPV=diastolic blood pressure variability, TT=tympanic temperature, 
ASBF=acral skin blood flow.   
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after standing upright, during moderate physical exercise and during a hot bath. Less
convincing evidence indicates an increased tendency to faint and to feel dizzy after
heavy meals. As for thermoregulatory autonomic control, there is evidence that CFS
patients more often experience sudden changes in skin color, a sudden paleness of
skin, shivering hands, sweating, and feeling unusually warm after standing upright and
after moderate physical exercise. A sudden redness of skin is rarer among CFS patients
than controls. Less convincing evidence indicates that CFS patients tend to feel unusually
warm after a hot bath.
3.2.2 Cardiovascular, neuroendocrine and thermoregulatory variables during
supine rest
Examination of the patient reported in paper I revealed supine tachycardia. Table 9
summarizes the results during supine rest reported in paper II-V. As for cardiovascular
variables, there is firm evidence of increased HR and decreased SI among CFS patients,
and also evidence of increased MBP, DBP, and TPRI and decreased EDVI. Less
convincing evidence indicates decreased ACI among CFS patients. As for neuro-
endocrine variables, there is evidence of increased plasma norepinephrine and epi-
nephrine. As for thermoregulatory variables, there is evidence of increased TT, whereas
less convincing evidence indicates decreased ASBF Left and Right.
3.2.3 Cardiovascular responses to orthostatic stress alone and combined with
isometric exercise
Examination of the patient reported in paper I revealed orthostatic tachycardia and
hypotension that normalized during treatment with propranolol. Table 10 summarizes
the results reported in paper II-IV. When orthostatic stress is applied in isolation, there
is firm evidence of a greater increase in HR, MBP, DBP, and TPRI and a greater decrease
in SI among CFS patients. There is also evidence of altered heart rate variability, with
a greater increase in LFnorm and LF/HF-ratio and a greater decrease in HFnorm among
CFS patients. Less convincing evidence indicates a greater increase in ACI among
CFS patients. When isometric exercise is perfomed in addition to orthostatic stress,
there is evidence of a smaller increase in HR and DBP and a smaller decrease in SI
among CFS patients. There is less convincing evidence of a smaller increase in MBP
and TPRI in this situation.
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3.2.4 Cardiovascular, neuroendocrine and thermoregulatory responses to local
cold stress
Table 11 summarizes the results reported in paper V. During strong cooling, evidence
indicates similar changes in the neuroendocrine variables among both CFS patients
and controls. During moderate cooling of the left hand, there is evidence of a greater
decrease in TT and a smaller decrease in ASBF Left among CFS patients, and there is
less convincing evidence of a smaller decrease in ASBF Right among CFS patients.
Table 10. Changes in cardiovascular variables during orthostatic stress – 
summary of results comparing CFS patients to healthy controls 
Variables During HUT During LBNP During LBNP 
and handgrip 
Cardiovascular variables 
ǻ HR Ĺ Ĺ Ļ
ǻ SBP Ĺ n.d. n.d. 
ǻ MBP Ĺ Ĺ (Ļ)
ǻ DBP Ĺ Ĺ Ļ
ǻ SI Ļ (Ļ) Ĺ
ǻ TPRI Ĺ (Ĺ) (Ļ)
ǻ EDVI n.d.
ǻ ACI (Ĺ)   
ǻ HRV, LFnorm Ĺ   
ǻ HRV, HFnorm Ļ   
ǻ HRV, LF/HF Ĺ   
ǻ HRV, time indices n.d.
ǻ DBPV, LFnorm n.d.   
ǻ DBPV, HFnorm n.d.   
Arrow=significant difference, direction indicating how CFS patients deviate from controls.  Arrow in 
parentheses=non-significant tendency. n.d.=no difference. HR=heart rate, SBP=systolic blood 
pressure, MBP=mean arterial blood pressure, DBP=diastolic blood pressure, SI=stroke index, 
TPRI=total peripheral resistance index, EDVI=end diastolic volume index, ACI=acceleration index, 
HRV=heart rate variability, LFnorm=low frequency, normalized units, HFnorm=high frequency, 
normalized units, DBPV=diastolic blood pressure variability.   
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Table 11. Changes in cardiovascular, neuroendocrine and thermoregulatory 
variables during local cold stress – summary of results comparing CFS 
patients to healthy controls 
Variables During strong cooling During moderate 
cooling 
Cardiovascular variables 
ǻ HR  n.d. 
ǻ MBP  n.d. 
Neuroendocrine variables 
ǻ Plasma norepinephrine n.d.  
ǻ Plasma epinephrine n.d.  
ǻ Plasma dopamine n.d.  
ǻ Plasma metanephrines n.d. 
Thermoregulatory variables 
ǻ TT  Ļ
ǻ ASBF Left (cooled)  Ĺ
ǻ ASBF Right (non-cooled)  (Ĺ)
Arrow=significant difference, direction indicating how CFS patients deviate from controls.  Arrow in 
parentheses=non-significant tendency. n.d.=no difference. HR=heart rate, MBP=mean arterial 
blood pressure, TT=tympanic temperature, ASBF=acral skin blood flow.   
3.2.5 Comparison of CFS patients with sedentary controls
As discussed more in depth below, some of the results among CFS patients could
theoretically be explained by sedentary deconditioning (see 4.2.4). To explore this
possibility, we extracted those controls that reported 4 hours or less of physical activity
per week (‘sedentary controls’, n=26), and compared this subgroup with CFS patients
in regards to the most important variables from paper IV and V.
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The two groups had an equal distribution of gender, age, weight and height (Table 12).
At rest, the values among sedentary controls were almost identical to the values of the
control group as a whole (Table 13). When comparing sedentary controls with CFS
patients, tests of significance revealed the same results as when all the controls were
compared with CFS patients, cf. Table 9. During orthostatic stress, the sedentary controls
had a smaller increase in HR, DBP and TPRI than the undivided control group, thus
amplifying the differences in regards to the CFS patients, cf. Table 10. During orthostatic
stress combined with isometric exercise, the sedentary controls had a greater increase
in HR than the control group as a whole, thus heightening the differences with the CFS
patients, but a smaller increase in TPRI. During moderate cooling, the sedentary controls
and the undivided control group responded almost identically; thus, they differed from
CFS patients to the same extent, cf. Table 11.
3.2.6 Quality of data during LBNP with handgrip
As described above, two identical runs of LBNP with handgrip were carried out with
each participant (see 2.2.1), making possible an assessment of the quality of the obtained
data. For each pair of observations of HR, DBP and SI among the healthy controls, the
difference was calculated and plotted against the mean, as suggested by Bland & Altman
(28). The differences were appraised to be independent of the mean value, and
conventional normality plots indicated an approximate normal distribution of these
variables, justifying parametric methods. Thus, 95 % empirical range of the mean
Table 12. Characteristics of sedentary controls (physical exercise  4 
hours/week) vs. CFS patients 
Variable Sedentary 
controls 
CFS
Number 26 15
Female gender 17 (65 %) 10 (67 %) 
Mean 
Age (years) 16 15
Weight (kg) 64 59
Height (cm) 172 171
Reported physical exercise (hours/week)  3.3 0.7
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Table 13. Sedentary controls compared with CFS patients for selected 
variables (cf. paper IV and V) 
Variable Controls 
(n=57)* 
Sedentery 
controls 
(n=26)* 
CFS
(n=15)* 
p-value, 
CFS vs 
sedentary 
controls†
At rest 
       
HR (beats/min), mean  65.7 66.7 75.8 0.03
       
DBP (mm Hg), mean 65.0 65.7 70.1 0.06
       
TPRI (mm Hg/l/min/m2), mean 11.1 11.0 11.6 0.59
       
Norepinephrine (pmol/L), 
median 
1156 1263 1646 0.06
       
Epinephrine (pmol/L), median 171 164 216 0.03
       
ASBF Left (a.u.), median 322.2 331.6 249.9 0.19
       
ASBF Right (a.u.), median 271.2 273.5 122.3 0.17
       
TT (oC), median 35.96 36.00 36.41 0.06
Changes during orthostatic 
stress (LBNP) 
       
ǻ HR (beats/min), mean  6.6 5.0 12.4 0.004 
       
ǻ DBP (mm Hg), mean 2.2 2.0 4.8 0.03
       
ǻ TPRI (mm Hg/l/min/m2), 
mean 
2.7 2.4 3.9 0.10
Changes during orthostatic 
stress + isometric exercise 
(handgrip) 
       
ǻ HR (beats/min), mean  8.9 11.5 2.6 0.002 
       
ǻ DBP (mm Hg), mean 8.4 8.0 5.3 0.03
       
ǻ TPRI (mm Hg/l/min/m2), 
mean 
2.2 1.6 1.1 0.36
Changes during moderate 
cooling 
       
ǻ ASBF Left (a.u.), median –267.6 –271.7 –132.7 0.03
       
ǻ ASBF Right (a.u.), median –39.0 –41.5 1.4 0.10
       
ǻ TT (oC), median 0.08 0.04 –0.22 0.19
* For some variables, the totals are slightly lower, cf. paper IV and V. 
†
 Wilcoxon-Mann-Whitney’s test, 2-sided 
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differences could be calculated from the standard deviations and gives an impression
of agreement between the two situations, whereas the mean differences with
corresponding 95 % confidence intervals reveal possible biases (28, 40). The results
are displayed in Table 14. Except for HR during LBNP, the mean differences are small
and the confidence intervals include zero.
Table 14. Mean differences (95 % confidence intervals) [95 % empirical 
range]* of cardiovascular variables in healthy controls (n = 55)† during two 
consecutive runs of LBNP 
Variables Baseline During LBNP During LBNP and 
handgrip 
HR (beats/min) –0.5 2.5 1.0 
 (–1.7 - 0.7) (0.6 - 4.4) (–0.9-2.8) 
 [–9.2 - 8.3] [–11.5 - 16.6] [–12.7 - 14.6] 
DBP (mm Hg) –0.03 1.3 1.7 
 (–1.8 - 1.7) (–-0.2 - 2.9) (–0.5 - 3.9) 
 [–12.8 - 12.8] [–10.4 - 13.1] [–14.5 - 17.9] 
SI (ml/m2) –0.3 –0.5 0.1 
(–1.6 - 1.1) (–1.8 - 0.7) (–1.2 - 1.5) 
[–10.6 - 10.1] [–9.7 - 8.7] [–9.7 - 10.0] 
    
* Based upon parametric methods (40). 
† One subject underwent only one single run of LBNP, and was therefore excluded from this 
analysis (see 2.2.1). 
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4 Discussion
4.1 Answers to the research questions
4.1.1 Symptoms of altered cardiovascular and thermoregulatory autonomic control
In general, our questionnaire results confirm that CFS patients have symptoms of altered
cardiovascular and thermoregulatory autonomic control. As far as we know, these clinical
phenomena have never before been systematically explored and charted.
Dizziness, which is reported more frequently among CFS patients, is an ambiguous
term; unknowingly people often (incorrectly) use it to describe vertigo (446). However,
when it occurs in circumstances known to challenge cardiovascular regulation (upright
position, physical exercise, hot surroundings, heavy meals), the most likely underlying
mechanism is a reduced brain perfusion due to either hypotension or cerebral
vasoconstriction. The increased tendency to faint among these patients supports this
conclusion.
The experience of feeling unusually warm is also difficult to interpret in terms of
underlying mechanisms. This symptom may accompany hypotension, and should in
that case be interpreted as a sign of altered cardiovascular control (402). However, the
‘hot flush’ characteristically affecting menopausal women is caused by cutaneous
vasodilation and thereby increased skin temperature, possibly due to altered
noradrenergic control of skin blood vessels (9). A sudden paleness of skin, on the other
hand, directly indicates cutaneous vasoconstriction due to increased sympathetic outflow.
Accordingly, increased tendency to sweat and shiver indicates enhanced sympathetic
outflow to sweat glands and skeletal muscles, respectively (155).
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4.1.2 Cardiovascular, neuroendocrine and thermoregulatory variables during
supine rest
Our results show substantial alterations of cardiovascular, neuroendocrine and
thermoregulatory variables in CFS patients at rest. As far as we are aware, such an
extensive investigation of baseline values has not been undertaken before; however,
there are scattered reports of similar findings (208, 231, 305, 370, 413).
As arrhythmia was ruled out during ordinary clinical examinations, the increased resting
HR among CFS patients indicates enhanced sympathetic or attenuated parasympathetic
cardiac nerve activity, possibly a combination (155). Alternatively, this finding could
be explained by increased levels of circulating epinephrine. Decreased SI in CFS patients
might suggest low contractility due to myocardial dysfunction; however, a more
immediate explanation is reduced filling, supported by the observed tendency towards
decreased EDVI. The latter, in turn, might signal reduced blood volume or increased
venous capacitance, but could also be directly related to high HR and correspondingly
low filling time (116).
The resistance in the arterioles of skeletal muscles is the main contributor to TPRI in
most physiological states (353). Thus, a tendency towards increased TPRI among CFS
patients indicates skeletal muscle vasoconstriction, which – in turn – is strongly
suggestive of increased sympathetic nerve activity, as circulating catecholamines have
a vasodilative effect in skeletal muscles (155).
Arterial blood pressure and body temperature are the controlled variables in the reflex
circuits ensuring cardiovascular and temperature homeostasis (see 1.2.2). Therefore, a
tendency towards increased MBP and DBP as well as TT among CFS patients directly
suggests altered set-point values for the cardiovascular and thermoregulatory control
systems. According to Goldstein, such homeostat resetting is a hallmark of distress
(155). All other factors being equal, the maintenance of cardiovascular homeostasis in
this situation requires increased sympathetic modulation of the heart and arterioles.
Similarly, maintenance of thermoregulatory homeostasis requires enhanced sympathetic
outflow to skin blood vessels and skeletal muscles, causing vasoconstriction and
shivering.
A high level of norepinephrine in the antecubital vein plasma of CFS patients might
suggest increased sympathetic nerve activity to forearm skin and skeletal muscle (156).
Likewise, a high plasma level of epinephrine is most likely a result of increased
sympathetic nerve activity to the adrenals. However, because high levels of plasma
catecholamines could result from either increased spill-over or reduced removal, which
in turn depends upon both sympathetic nerve activity, the capacity of different reuptake-
and breakdown-pathways, and local blood flow (155, 156), there are several alternative
explanations as well.
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4.1.3 Cardiovascular responses to orthostatic stress
Abnormal cardiovascular responses to orthostatic stress, as documented in this thesis,
are perfectly in line with a number of other reports (35, 231, 306, 339, 340, 383, 386,
387). However, an exeriermental set-up combining orthostatic stress and isometric
exercise has not been undertaken before; thus, our findings of attenuated cardiovascular
responses among CFS patients in this particular situation appear to be novel.
The greater increase in HR in relation to orthostatic stress in CFS patients suggests
enhanced sympathetic and/or attenuated parasympathetic cardiac nerve activity (155).
This notion is further supported by the analyses of heart rate variability, in which the
greater increase in LFnorm and LF/HF-ratio and greater decrease in HFnorm among CFS
patients indicates a sympathetic predominance in the modulation of the sinoatrial node
(258, 296, 346). As outlined above, a greater decrease in SI might be ascribed to the
HR influence on filling time (116); reduced contractility due to myocardial dysfunction
seems unlikely, as ACI tended to be higher in CFS patients than in controls.
Following the reasoning from 4.1.2, a greater increase in TPRI among CFS patients
suggests a stronger sympathetically mediated vasoconstriction in skeletal muscles.
Furthermore, a greater increase in MBP and DBP might be a consequence of bringing
the set-point to an even higher level, thus redefining the range of homeostasis (155).
The cardiovascular responses to combined orthostatic stress and isometric exercise
might be considered a ‘mirror image’. The smaller increase of HR among CFS patients
is consistent with attenuated sympathetic cardiac responses (184). Similarly, a tendency
towards a smaller increase of TPRI suggests attenuated sympathetic outflow to skeletal
muscle arterioles. Again, the differences in SI among the two groups might be a
consequence of the different HR responses, whereas a smaller increase of MBP and
DBP among CFS patients suggests an inability to raise the set-point in this particular
situation.
4.1.4 Cardiovascular, neuroendocrine and thermoregulatory responses to local
cold stress
Mechanisms of thermoregulation have hardly been explored among CFS patients, and
we are not aware of any study that has applied experimental methods similar to ours.
Thus, our findings regarding responses to local skin cooling appear to be unique to this
thesis.
The similar neuroendocrine response to strong cooling among CFS patients and controls
indicates that this stressor causes an identical general enhancement of sympathetic
nerve activity in both groups. Thus, CFS patients have preserved reflex arches and
response abilities within the sympathetic nervous system.
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Blood flow through arteriovenous anastomoses (AVAs) is the main determinant of ASBF
(23, 251). These vessels are sympathetically innervated. Thus, a smaller decrease of
ASBF Left among CFS patients during cooling of the left hand (and a similar tendency
towards smaller decrease of ASBF Right) indicates attenuated sympathetic nerve activity
to the AVAs. Alternatively, this result might be explained by a defect in local
vasoconstrictor mechanisms. Furthermore, in CFS patients, TT decreased during the
moderate cooling experiment, suggesting a normalization of the thermoregulatory set-
point value. As outlined above, attenuated sympathetic outflow to skin blood vessels
would be an expected consequence of such resetting (see 4.1.2), fitting neatly with the
observed ASBF data.
4.1.5 Concluding remarks
Taken as a whole, we have provided firm evidence of altered sympathetic nerve activity
among CFS patients, supporting the hypotheses of sympathetic dysfunction as essential
in CFS pathophysiology (137, 151, 159, 282, 297). More specifically, and in relation
to our research questions, we conclude that:
A. CFS patients have symptoms of altered cardiovascular and thermoregulatory
autonomic control. Some of the thermoregulatory symptoms directly suggest
enhanced sympathetic nerve activity to the sweat glands, the skeletal muscles and
the skin vessels.
B. During supine rest, CFS patients seem to have increased sympathetic nerve activity
to the heart, the skeletal muscle arterioles and the adrenals; the latter causing increased
plasma levels of epinephrine. In addition, there is evidence of increased set-point
values for arterial blood pressure and body temperature among CFS patients.
C. During orthostatic stress, CFS patients seem to have enhanced sympathetic nerve
activity to the heart and the skeletal muscle arterioles, as well as a greater increase
in the arterial blood pressure set-point. However, when orthostatic stress is combined
with isometric exercise, CFS patients seem to have attenuated sympathetic
cardiovascular outflow and a smaller increase in the arterial blood pressure set-
point.
D. During local cold stress, CFS patients and healthy controls have similar sympathetic
responses to strong cooling. However, during moderate cooling, CFS patients seem
to have attenuated sympathetic outflow to skin arterioles, combined with a
normalization of the set-point value for body temperature.
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4.2 Possible explanations of altered sympathetic nerve activity
in CFS
Altered sympathetic nerve activity, as documented among CFS patients in this thesis,
might stem from several physiological or pathological states. In the following,
hypovolemia, oxidative stress, the postural orthostatic tachycardia syndrome, sedentary
deconditioning, gravitational deconditioning, and disturbances of CNS autonomic
control will be discussed thoroughly in relation to our findings.
4.2.1 Hypovolemia
Two prior studies have indicated absolute (126) or relative (396) hypovolemia in CFS
patients (see 1.3.2). A reduction in central blood volume is registered by cardiopulmonary
receptors, causing altered afferent neural transmission to the brain stem cardiovascular
control center (155). The reflex response consists of increased sympathetic outflow to
the heart, to the arterioles of the kidneys and skeletal muscles, and possibly to other
vascular beds as well (including the splanchnic circulation), as outlined in detail above
(see 1.2.2). As for alterations in arterial blood pressure, present evidence is somewhat
conflicting; e.g., Zollai et al. reported increased SBP, MBP and DBP after blood donation
(460), whereas Triedman et al reported the opposite (418). However, when hypovolemia
is experimentally induced by diuretics or simulated by low-level LBNP, most studies
seem to find unaltered blood pressure values (141, 144, 219, 431). Hypovolemia tends
to increases the levels of plasma norepinephrine, but not plasma epinephrine (140,
144).
When orthostatic stress is applied in a hypovolemic state, the cardiovascular sympathetic
responses are generally augmented as compared to normovolemia (141, 193, 219, 220,
418). Arterial blood pressure, however, tends to stay unaltered (141, 219, 418). No
studies specifically address the influence of hypovolemia upon combined orthostatic
stress and isometric exercise. However, a couple of studies indicate an upper limit of
vasoconstriction mediated by sympathetic nerve activity (140, 354). Such a ‘saturation’
phenomenon implies that high resting sympathetic activity will influence negatively
the sympathetic vasoconstrictor responses to added stressors. Furthermore, norepine-
phrine has negative feedback-effects on sympathetic neurotransmission within the
cardiovascular system; the functional importance is probably most pronounced during
conditions of high sympathetic outflow (419). Whether these mechanisms apply to
sympathetic control of all organs remains to be demonstrated.
Whether hypovolemia influences thermoregulation has been only scarcely explored in
experimental studies. However, there is some evidence of an opposite causal relationship.
For instance, a recent study concluded that hyperthermia attenuates the baroreflex-
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controlled increase in cardiovascular sympathetic activity during transient hypotension
(451). However, local cooling or heating of skin did non influence the baroreflex
response (450). Others have found that local cold stress might provoke sympatho-
inhibition during orthostatic stress (247), and that heat stress enhances the skeletal
muscle sympathetic response during orthostatism (87).
In this thesis, hypovolemia might explain our assumption of increased sympathetic
outflow to the heart and the skeletal muscle arterioles when CFS patients are at rest, as
well as their enhanced sympathetic cardiovascular responses during orthostatic stress.
Furthermore, hypovolemia is also compatible with attenuated sympathetic responses
to combined orthostatic stress and isometric exercise, due to the ‘saturation phenomenon’
as described above. However, hypovolemia does not explain increased levels of epine-
phrine nor increased set-point values for arterial blood pressure and body temperature
at rest. The further increase of blood pressure set-point during orthostatic stress is also
inexplicable, as well as the observed response to moderate cooling. Finally, volume
expansion treatment (fludrocortisone) in CFS has no documented effect (309, 341). In
conclusion, hypovolemia seems to be an unlikely cause of the autonomic alterations
documented in this thesis.
4.2.2 Oxidative stress
Several studies have documented increased oxidative stress among CFS patients,
especially in the skeletal muscles (197, 425). This state may increase afferent neural
activity, and thereby enhance resting sympathetic outflow to skeletal muscle arterioles
through a reflex mechanism (155, 324). During orthostatic stress, such a mechanism
might possibly cause enhanced sympathetic responses; interestingly, the attenuated
responses to added isometric exercise are also compatible with such an explanation
(264).
However, oxidative stress in the skeletal muscles does not readily explain the altered
cardiac autonomic control, the set-point alterations, the increased baseline epinephrine
level nor the skin responses to moderate cooling. Overall, we believe that increased
oxidative stress does not comply with the results presented in this thesis.
4.2.3 Postural orthostatic tachycardia syndrome (POTS)
As exemplified in paper I, there appears to be a relationship between the postural
orthostatic tachycardia syndrome (POTS) and CFS, both in adults (127) and adolescents
(383), although this relationship is questioned in some later reports (201). POTS
designates a condition characterized by an increase in HR of more than 30 beats/minute
during a head-up tilt test, accompanied by unpleasant symptoms (such as
lightheadedness, palpitations and nausea) (384). Hypotension may occur, but is not a
prominent feature.
63
The pathophysiology of POTS is undetermined, but seems to involve efferent
sympathetic neurons and/or adrenergic synapses. At rest, POTS patients tend to have
an increased heart rate (33, 157, 383), and detailed studies of norepinephrine kinetics
confirmed increased sympathetic cardiac activity (158). Some researchers have reported
increased arterial blood pressure as well (33, 158). Furthermore, there are reports of
enhanced resting sympathetic outflow to skeletal muscles (145) together with increased
muscle blood flow (389), pointing towards a vasoconstrictor defect. However, the
evidence is conflicting (33, 158).
The level of plasma norepinephrine in upper limb venous blood is usually elevated
(157, 359); some studies also report increased levels of epinephrine (157). In lower
limb venous blood, however, norepinephrine levels tend to be lower than normal;
furthermore, the transmitter turnover during different sympathoexcitatory stimuli is
impaired, suggesting reduced neuronal reuptake and a ‘patchy’ sympathetic denervation
predominantly affecting the legs (194, 195). However, a reuptake failure does not
necessarily imply neuronal degeneration, and a mutation in the norepinephrine reuptake
protein has indeed been documented in a pair of twins suffering from POTS (358).
A low level of LBNP does not seem to affect HR or MBP in POTS patients (158).
However, in some studies, orthostatic stress is associated with attenuated sympathetic
nerve activity to skeletal muscles (145) and blunted arterial vasoconstriction (385),
causing ‘pooling’ in the dependent limb. Accordingly, similar results have been obtained
during pharmacologically induced hypotension (33), further indicating some sort of
sympathetic denervation, although the evidence is conflicting (279). Thus, the marked
HR increase in regards to more severe orthostatic stress is regarded as a physiological
response to reduced cardiac filling due to a peripheral vasoconstrictive defect. Recent
evidence indicates that the mechanisms causing reduced cardiac filling might vary,
suggesting a subgrouping of POTS patients; however, the mechanism for the HR
response, which constitutes the hallmark of the disease, seems to remain identical (388).
Our results do not seem to support a close relationship between POTS and CFS
pathophysiology. Our findings of increased TPRI at rest and enhanced TPRI during
orthostatic exercise among CFS patients is neither consistent with sympathetic
denervation nor any other vasoconstrictive defects. This notion is further supported by
the neuroendocrine responses to strong cooling, indicating preserved reflexes and
response abilities within the sympathetic nervous system; importantly, a similar test in
POTS patients showed attenuated responses (194). Finally, the set-point alterations of
arterial blood pressure and body temperature do not seem to be a feature of POTS.
4.2.4 Sedentary deconditioning
The CNS patients included in this study reported a significantly lower level of physical
activity than the healthy controls (Table 7). Sedentary deconditioning and reduced
aerobic capacity should therefore be considered a possible cause of the experimental
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results, as endurance training has a substantial influence on cardiovascular regulation
(291). Recent evidence indicates that this is partly explained by alterations of CNS
autonomic control, but other mechanisms are also involved; for instance, physical
exercise increases blood volume, which in turn exerts a tonic load on cardiopulmonary
receptors (168).
Regular exercise causes a substantial decrease in resting HR, which is probably a
combined result of increased SV due to hypertrophy, and central attenuation of cardiac
sympathetic drive (290). Furthermore, there is evidence of lowered TPR and muscle
sympathetic nerve activity, contributing to a small but significant decrease in resting
blood pressure (82, 165, 291). Plasma levels of norepinephrine are reduced (82), as are
possibly also the levels of epinephrine (291, 329). Thus, physical exercise is established
as an important therapy in patients with hypertension (82).
Although lowering basal activity, endurance training seems to enhance the
responsiveness within the sympathetic nervous system, at least in some situations. For
instance, Grassi et al. documented a greater increase in HR and muscle sympathetic
nerve outflow during drug induced hypotension after a period of physical training (165).
Kjær reported enhanced adrenal responsiveness in trained subjects compared to
sedentary controls during non-exercise stimulation (221). However, the evidence is
somewhat conflicting, as other researchers have documented attenuated sympathetic
responses to dynamic exercise after a training period (322). Interestingly, reduced
responsiveness among the well-trained seems to be even more pronounced during
isometric exercise; several studies have reported both attenuated HR increase (290)
and attenuated sympathetic muscle nerve activity (377) in handgrip experiments.
Unfortunately, there are contradicting findings in this area as well (323).
A detailed study by Levine et al. compared the responses to LBNP among subjects
having different fitness levels (241). The responses to low level LBNP was rather similar
in high-fit, medium-fit and low-fit individuals; however, compared to the low-fit group,
the medium-fit tended to have a greater increase in HR and a smaller increase in TPR.
More or less identical results have been reported by others (246, 285), indicating that
moderate endurance training does not significantly influence the responses to orthostatic
stress. However, intense endurance training is associated with reduced orthostatic
tolerance, possibly due to structural alterations of muscle veins causing increased pooling
(291).
Physical training is reported to enhance both the sweating and the vasodilator responses
to a new bout of exercise (134). Accordingly, training might prevent the attenuation of
thermoregulatory responses that are associated with bed-rest or reduced gravity (86,
363). However, the evidence is somewhat conflicting (181). Conversely, there is also
evidence of reduced thermogenic threshold and elevated thermogenic sensitivity among
endurance-trained subjects when exposed to a cold environment (196, 348).
Our findings of increased blood pressure, HR, TPRI and catecholamines at supine rest
among CFS patients seem to fit with a hypothesis of sedentary deconditioning. Likewise,
attenuated sympathetic skin response to moderate cooling might be explained by this
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mechanism. However, the enhanced sympathetic responses to orthostatic challenge
among CFS patients and the equal responsiveness to strong cooling among the two
groups do not seem to fit this model. Furthermore, the attenuated responses to isometric
exercise in CFS directly contradict what would be expected if sedentary deconditioning
was an important underlying cause. Finally, our subgroup analysis comparing CFS
with those controls that were least physically active (see 3.2.5) did not support such a
hypothesis. However, it should be noted that even the most sedentary controls were
more physically active than the CFS patients.
4.2.5 Gravitational deconditioning
A discrete, though related deconditioning phenomenon takes place during conditions
of reduced gravity (179). This has been extensively studied in astronauts following
space-flights. However, similar processes can also be observed during prolonged bed-
rest.
Resting HR tends to increase in individuals subjected to gravitational deconditioning
(75). This is probably caused by attenuated parasympathetic modulation of the sinoatrial
node (274), but there are also indications of reduced cardiac sympathetic activity,
although not to the same extent (75). Resting blood pressure values are unchanged (76,
192), whereas increased resting TPR is reported by most researchers, as reviewed by
Waters et al (433). Accordingly, gravitational deconditioning is related to increased
baseline sympathetic muscle outflow (242). Little is known about possible baseline
alterations in the nervous control of skin circulation. Resting plasma level of
norepinephrine tends to be lower (76, 160, 433), whereas epinephrine level seems to
remain unchanged (160, 433).
Gravitational deconditioning attenuates the normal responses to orthostatism (75). Thus,
strong orthostastic stress might precipitate syncope, whereas moderate orthostatic stress
does not seem to influence blood pressure levels. The reduced orthostatic tolerance is
explained partly by a combination of hypovolemia and increased venous compliance,
causing a substantial reduction in central venous pressure (75, 192). Another important
underlying mechanism is probably a blunted increase in TPR, as has been demonstrated
both in healthy subjects following bed-rest (365), in astronauts following spaceflights
(48), and in animal models (179). Accordingly, Kamiya et al reported an attenuated
increase in skeletal muscle sympathetic outflow during orthostatic stress (204). However,
the evidence is not uniform, as enhanced TPR responses have also been found by some
researchers (76). Furthermore, the HR increase connected to orthostatic stress has been
reported to be less pronounced after gravitational deconditioning due to a reduced
responsiveness of the baroreflex (75); however, enhanced HR responses have been
documented in other studies (433).
Ample evidence indicates that gravitational deconditioning influences the mechanisms
involved with heat loss, in particular during physical activity (85, 239). Also, a higher
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core temperature has been observed (273). The causes of this phenomenon seem to be
impaired sweating as well as vasodilator responses; more specifically, evidence indicates
both an increased threshold and reduced gain (273). Hypovolemia seems to be an
important underlying explanation, but other mechanisms involving post-synaptic
alterations of effector tissue are probably involved as well (86, 135). Recently obtained
evidence suggests that prolonged bed-rest might cause attenuated cold-induced
vasoconstriction and shivering responses as well (270). In the study of Mekjavic et al.,
the vasoconstrictor defect was attributed to the mechanical effects on vessels during
microgravity, whereas reduced skeletal muscle function due to atrophy and attenuated
central activation may account for less shivering. Accordingly, gravitational
deconditioning seems to attenuate the response to the cold pressor test (432).
Gravitational deconditioning might explain our observations of increased HR and TPR
among CFS patients at rest, and possibly also the increased body temperature and
attenuated vasoconstrictor responses to moderate cooling. However, the neuroendocrine
values at rest and during strong cooling, the changes in blood pressure set-point at rest
and during orthostatic challenge, and finally the enhanced sympathetic cardiovascular
response during orthostatic stress does not support gravitational deconditiong as an
important underlying mechanism. In addition, none of the CFS patients were
permanently bedridden (Table 7), and even very limited gravitational stimuli seem
sufficient for preserving normal cardiovascular reflexes (406).
4.2.6 Disturbances of CNS autonomic control
As outlined above (see 1.2.2), all homeostatic control circuits operate according to a
defined set-point. In some situations, the set-point level is altered, thus redefining the
homeostatic range (155). For instance, both dynamic and isometric exercise is related
to resetting of the baroreflex, whereas orthostasis normally is not. Fever is the most
thoroughly studied example of set-point resetting within the thermoregulatory system,
caused by the effect of inflammatory mediators on the hypothalamic thermoregulatory
control areas (332). More generally, set-point changes should be considered vital for
the CNS control and modulation of organ physiology. However, the neuronal substrates
responsible for such changes remain largely unknown. A possible mechanism is relative
alterations in activity among different brain centers. Thus, the set-point of a given
control circuit is not localized to a single anatomical structure, but depends upon the
dynamic interplay within neuronal networks (155).
The evidence presented in this thesis directly suggests altered resting set-point levels
for blood pressure and body temperature among CFS patients. However, there are
alternative explanations. The increased blood-pressure during orthostatic stress might
be attributed to an overshooting-mechanism, causing a discrepancy between the real
and the ‘desired’ value. Likewise, the attenuated blood pressure increase during isometric
exercise might indicate an inability to raise the blood pressure to the desired level,
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analogous to what occurs during some variants of orthostatic hypotension (159). Still,
both findings are more readily explained by a resetting disturbance; in particular, the
permanently increased blood pressure level during orthostatic stress does not seem to
fit well with an overshooting-mechanism, which would be anticipated as a more transient
phenomenon.
As homeostat resetting is a specific CNS phenomenon (155), our findings among CFS
patients indicate a disturbance of CNS autonomic control. In turn, such a disturbance
might explain other findings. An increased blood-pressure set-point at rest implies
increased sympathetic outflow to the heart and the skeletal muscles, causing higher
HR and TPR (see 1.2.2). Further elevation of the set-point during orthostatic stress
elicits enhanced sympathetic cardiovascular activity, explaining a further increase in
HR and TPR. A restricted set-point elevation during isometric exercise, on the other
hand, has the opposite effect on sympathetic efferents, resulting in attenuated HR and
TPR-responses. Furthermore, an increased body temperature set-point at rest implies
increased sympathetic nerve activity to the sweat glands, the skeletal muscles and the
skin vessels, in accordance with the patient’s symptoms and their tendency towards
reduced perfusion of arteriovenous anastomoses. Normalization of the set-point during
moderate cooling reduces the sympathetic outflow to arteriovenous anastomoses,
resulting in higher acral skin blood flow.
4.2.7 Concluding remarks
When seen as a whole, we conclude that the altered sympathetic nerve activity
demonstrated among CFS patients most likely is caused by disturbances of CNS
autonomic control characterized by abnormal homeostat resetting. In other words, altered
CNS autonomic responsiveness seems to be an important aspect of CFS patho-
physiology. Using Goldstein’s terminology, CFS might be regarded a disease of ‘homeo-
dynamics’ (155).
Interestingly, this statement seems perfectly in line with Friedman’s publication from
1945 describing ‘neurocirculatory asthenia’, in which he concludes (138): «Changes
in the rate, rhythm, and force of cardiac contractions were observed […] to be proceeded
by, or associated with, excitation of the sympathetic nervous system. […] Evidence
was obtained which suggested that the excitation […] resulted from hypothalamic
discharge.»
This conclusion has important implications. The homeostatic control circuits are
intimately related to the concept of stress (see 5.1.1). According to Goldstein, distress
defines a specific kind of stress, characterized by homeostatic resetting for one thing
(155). Increased plasma levels of epinephrine, also demonstrated among our CFS
patients, is another hallmark of distress. Thus, a possible relationship between CFS
and stress/distress merits further consideration, as will be comprehensively discussed
in section 5.
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4.3 Methodological considerations and study limitations
4.3.1 Recruitment
The uncertainties related to the CDC definition of CFS and our reasons for not adhering
strictly to it have been extensively discussed elsewhere (see 1.3.1). Theoretically, the
main disadvantage of our chosen approach seems to be the risk of grouping together
conditions that have different etiology or pathophysiology, possibly obscuring important
scientific findings. In addition, only a subgroup of the patients underwent expert
psychiatric assessment at our institution (see Table 4), further increasing the possibility
of heterogeneity. In other words: we were at risk of performing a type II-error. However,
we did find statistical significant differences between patients and controls, even though
the sample sizes were quite small. This fact seems to constitute an indirect justification
of our inclusion criteria, bringing the validity of the CDC definition into question.
A logical consequence seems to be increased generalizability of our results. In fact,
they might apply to all patients having long lasting, unexplainable and disabling fatigue,
regardless of additional symptoms. However, this generalization is narrowed for two
other reasons; we only studied adolescents, and the patients were recruited from a
national referral center. Thus, further research projects should be population based and
include a wider age group.
The possibility of sedentary deconditioning among CFS patients has been thoroughly
outlined above (see 4.2.4). Although existing evidence does not support deconditioning
as an explanation for the observed abnormalities, more sound proof might emerge
from research comparing CFS patients with controls who have the same level of physical
activity, and this should therefore be considered in the planning of new research.
4.3.2 Experimental protocols
Generally, the dynamic function of the autonomic nervous system might be assessed in
three different ways (155):
- By microneurography, an invasive technique recording the electrical bursts in
autonomic neurons.
- By neurochemical methods, implying invasive measurement of transmitter
substances and their metabolites.
- By recording end-organ adjustments, which might be performed invasively as
well as non-invasively.
Except for the experiment assessing neuroendocrine responses to strong cooling, we
used the latter approach, applying non-invasive techniques exclusively. This is a
substantial advantage, as all invasive procedures affect autonomic function in itself,
introducing a possible source of error. Besides, non-invasive methodology is usually
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considered ethically unproblematic. However, the shortcomings are obvious: end-organ
recordings provide only indirect information, resulting in interpretational caveats and
uncertainties, as illustrated by the comprehensive discussion on cardiovascular
variability-indices (112, 258). Ideally, therefore, the results reported in this thesis should
be confirmed by supplemental approaches such as microneurography and neurochemical
methods, as further discussed below (see 5.2.5).
As a compensation for relying predominantly upon one methodological approach, we
tested the same autonomic reflex mechanism by using two different experimental
protocols: the head-up tilt-test and the lower body negative pressure-test. The similar
results in these two experiments strengthen the validity of our conclusions. Furthermore,
alternating between patients and controls during the study period reduces the risk of
systematic errors (see 2.2.1).
Some particular problems related to the handgrip-part of the LBNP-experiment increase
the uncertainties of the obtained results. Substantial evidence indicates that the
cardiovascular responses during isometric exercise are independent of muscle mass,
but depend upon the relative tension of the contraction (189, 445). As the CFS patients
produced significantly less force during handgrip than did the healthy controls, one
possible explanation for the hemodynamic differences is simply that the patients did
not reach 30 % of their maximum handgrip capacity. Furthermore, the cardiovascular
adjustments during isometric exercise were not studied in isolation. Thus, we are unable
to tell whether or not orthostatic stress is a prerequisite for the observed reduced
sympathetic response during handgrip in the CFS group. Finally, the experimental
protocol demanded the repetition of the isometric exercise after a one-minute resting
period (see Figure 10), and long-lasting metabolic changes in the muscles during the
first bout might have influenced the cardiovascular responses during the second bout.
Other limitations of this study related to experimental set-up include:
- The participants were allowed to eat and drink on two occasions during the
experimental day (see Table 6). The intake of food and fluid might have
considerable influence on cardiovascular function (202, 366). However, since
the meals were standardized and offered at predefined times, they should not
contribute to differences between patients and controls.
- Baseline blood volume/plasma volume was not measured, leaving the question
of hypovolemia in CFS patients unresolved.
- Plasma catecholamines were not measured during orthostatic stress or moderate
cooling. A combined setup might have yielded additional information.
- Normetanephrine is the product of extraneuronal breakdown of catecholamines,
whereas dihydroxyphenylethylene glycol (DHPG) mainly results from
intraneuronal metabolism (155, 156). Concomitant measurement of this
metabolite would have given better insight into sympathetic nerve function.
- Respiratory activity has been shown to change during orthostatic stress, and
could therefore influence cardiovascular variability (79); however, ventilation
was not measured nor controlled in the HUT experiment.
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4.3.3 Quality of data
The technique of impedance cardiography applied during the HUT experiment might
have limited validity, as indicated in several reports (38, 263, 303). The evidence
supporting the validity of indices derived from the impedance signal, such as EDVI
and ACI, is even weaker, emphasizing the necessity for cautious interpretation.
Otherwise, as outlined above, the validity of the recording methods used in the different
experiments have been firmly established among healthy adults (see 2.2.1). However,
apart from the photopletysmographic technique of blood pressure measurements (356),
none of the methods have been thoroughly assessed when used with children and
adolescents, underscoring the need for further research projects addressing this issue.
The study design was aimed at minimizing influence of random error; most important,
all experiments were carried out by the same researcher. A more formal analysis of
random error within the LBNP experiment was made possible because each subject
was exposed to two identical consecutive experimental runs (see 2.2.1). As outlined in
3.2.6, in healthy controls the 95 % empirical range of the mean differences is about 20-
30 units wide for HR, DBP and SI, signaling quite low agreement between the two
experimental runs, and a correspondingly high degree of random error (see Table 14).
The quality of derived variables, such as TPRI, is even more reduced, as they are
influenced by random errors from different sources. However, the main consequence
of this phenomenon is increased risk of performing type II-errors. As we did find
significant differences among patients and controls, the presence of random errors seem
to have had limited impact.
Table 14 in 3.2.6 also visualizes a possible bias, as the mean difference of HR during
LBNP was significantly higher than zero. Thus, there seems to be a slight trend towards
higher HR in the second experimental run of LBNP as compared to the first one,
indicating that they were not totally independent of each other. A likely explanation
might be long lasting hormonal responses. However, as the protocols were identical
among patients and controls, this bias should not interfere with the observed differences
between the two groups.
71
5 Towards a unifying theory of the chronic
fatigue syndrome
In the previous section, we concluded that the altered sympathetic nerve activity
demonstrated among CFS patients is most likely caused by disturbances of CNS
autonomic control characterized by abnormal homeostat resetting (see 4.2.7). Thus,
the pathophysiology of CFS seems to be intimately linked to the concept of stress/
distress.
The first part of this section introduces a conceptual framework defining stress/distress
and rooting these conditions in mechanisms of biology and psychology. Thereafter, the
possible link between stress/distress and CFS will be thoroughly discussed in relation
to other research findings as reviewed in the introductory part of this dissertation (see
1.3.2). The aim is to develop a unifying, still comprehensive, theory on the
pathophysiology of CFS. Notably, this intellectual process is inductive, moving from
an empirical to a theoretical level. It will be followed by an analogous deductive process,
resulting in hypotheses that may be subjected to further research.
5.1 A conceptual framework
5.1.1 The stress theory of Goldstein
The autonomic nervous system – and the sympathetic branch in particular – has a key
role in the response to stress. ‘Stress’ might be considered an ambiguous term; however,
it is generally accepted as denoting a fundamental aspect of both physiology/
pathophysiology and psychology. Goldstein defines stress as «a condition in which
expectations, whether genetically programmed, established by prior learning, or deduced
from circumstances, do not match the current or anticipated perceptions of the internal
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or external environment, and this discrepancy between what is observed or sensed and
what is expected or programmed elicits patterned, compensatory responses» (155).
In Goldstein’s view, stress is intimately related to the concept of homeostasis and the
regulatory circuits described above (see 1.2.2) (155). In fact, stress occurs when
homeostasis is threatened by any external perturbation. Thus, situations like orthostasis,
exercise and cold exposure can all be considered ‘stressful’, eliciting a stress response,
of which the characteristics – the ‘pattern’ - is determined by the control circuit. For
instance, during orthostasis, the gravitational force will temporally disturb both arterial
blood pressure and cardiac filling. However, the body has an ‘expectation’ of the ideal
cardiac filling and arterial blood pressure levels, commonly referred to as the set-points.
In this case, such a discrepancy between the ideal and real values will elicit a stress
response characterized by a sympathetically induced increase in heart rate, contractility
and total peripheral resistance. It is important to note, however, that most stress responses
are not restricted to increased sympathetic (or reduced parasympathetic) nerve activity;
other important effector systems are the somatic nervous system (regulating behavior),
the adrenomedullary system (regulating plasma epinephrine), the hypothalamo-pituitary-
adrenocortical system (HPA axis, regulating plasma glucocorticoids), the renin-
angiotensine-aldosterone-system, and endogenous opioids.
It is evident that stress, as defined in this way, requires perception. In other words,
stress and stress responses always involve the central nervous system. However,
consciousness is not a prerequisite (155). In the example of orthostasis, the cardiovascular
control center, by means of the baroreceptors and cardiopulmonary receptors, perceives
a mismatch between the ideal and actual situation, but this mismatch is never experienced
by the conscious ‘self’. However, involvement of consciousness does not exclude a
condition from being stressful, corresponding to our common usage of these terms.
For instance, a trauma might be perceived – both consciously and unconsciously – a
threat to homeostasis. Furthermore, involvement in a traffic accident might be a
consciously anticipated homeostatic catastrophe even before any trauma has occurred,
eliciting a patterned stress response that includes behavior.
A similar distinction is also made in regards to the term ‘expectations’. According to
the definitions, expectations or the ‘ideal levels’ might be genetically programmed not
involving consciousness, as is presumably the set-point of the arterial baroreceptor
reflex, or they might be ‘deduced from circumstances’, denoting a conscious, mental
process. A third alternative, of particular importance in this thesis, is that expectations
might depend upon prior learning. In everyday language, ‘learning’ is usually
understood as an intellectual, highly conscious and voluntary activity. However,
numerous important learning processes, also in humans, can be classified as conditioning,
not involving consciousness or will (43). In classical conditioning, first described by
Pavlov, a neutral stimulus (e.g. bell ringing) is repeatedly paired with a stimulus (e.g.
presentation of food) that reflexively elicits a response (e.g. salivation). Associative
learning ensures that after a while, the neutral stimulus itself will give rise to the response.
In operant (instrumental) conditioning, a certain behavior is followed by positive
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reinforcement (reward) or negative reinforcement (punishment), which in turn – by
associative learning - increases or decreases the likelihood of the behavior. Thus, whether
a situation is perceived as stressful, and how we eventually respond to it, is highly
dependent upon the unconscious influences of our earlier experiences.
Distress can be defined as a specific kind of stress, characterized by a conscious
interpretation of a homeostatic threat in a broad sense (155). Thus, there is a close
analogy – or even an overlap – between a physiological and a psychological perspective,
the latter often defining distress as an inability to cope or a lack of controllability.
Furthermore, distress is related to aversiveness and therefore, by the means of the learning
processes described above, promotes withdrawal, escape and avoidance behavior. A
third characteristic of distress is observable signs reflecting the emotional state of the
organism, often produced by changes in sympathetic nerve activity; one example is
facial paleness which accompanies fear and facial flushing when one is angry. Fourth,
distress evokes a patterned endocrine response causing elevated plasma levels of steroid
hormones and epinephrine due to adrenocortical and adrenomedullary activation,
respectively. Some have proposed a sequence of endocrine responses, causing different
hormone levels in the early and late phases of distress (183). Finally, homoeostat resetting
(i.e., change of set-points in the control circuits) is by Goldstein regarded as a hallmark
of distress, causing a redefinition of homeostasis (155). However, in contrast to earlier
views, the response of the sympathetic nervous system is not uniform rather it is tailored
to the homeostatic challenges of the specific circumstances.
According to Goldstein, «situations evoking distress typically involve a complex
interplay of classically and operantly conditioned behaviors» (155). For instance, distress
might be percipitated by a neutral stimulus if it is associated with an event threatening
homeostasis (classical conditioning), leading to behavior that ensures avoidance of the
stimulus (operant conditioning). Repeated exposure to a stimulus evoking distress may
cause reduced responsiveness, a phenomenon known as habituation; however, the
organism might concurrently develop increased responsiveness to other potentially
stressful stimuli (dishabituation).
5.1.2 Supplemental stress theories
The cognitive activation theory of stress (CATS), developed by Ursin and co-workers
and based on experimental research with both animals and humans (118, 421), does
not seem to differ in any vital aspects from the theories formulated by Goldstein (155)
(see 5.1.1). However, the emphasis is somewhat different. CATS primarily focuses on
conditions that are consciously regarded a threat to homeostasis; thus, the term ‘stress’
in this theory seems to correspond to Goldstein’s use of ‘distress’. Furthermore, CATS
is concerned with the neuropsychological arousal elicited in stressful situations, and
how expectancies might modulate both the arousal itself and the subsequent
compensatory behavioral and autonomic/endocrine responses. In this regard, there are
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two possible types of expectancies: stimulus expectancy, which modulates arousal and
responses in terms of classical conditioning, and response outcome expectancy, which
influence would be that of operant conditioning. In relation to the latter, CATS defines
‘coping’ as an expectancy of possessing the ability to respond adequately; thus ‘coping’
is not related to the response itself, nor to the factual outcome of a given situation
(421). ‘Hopelessness’, on the other hand, occurs if the response abilities are expected
to be insufficient. ‘Helplessness’ is defined as a condition in which the response abilities
are expected to be irrelevant; i.e., the subject does not possess any means of preventing
a certain outcome.
When applied to illnesses, CATS presumes that a persistent state of hopelessness and
helplessness will result in sustained arousal, which on the neurobiological level might
be related to sensitization of certain neuronal circuits within the CNS (118, 421).
Hypothetically, this sustained arousal may cause a vast range of subjective bodily
complaints, as well as be responsible for detrimental effects on different organ systems,
such as an increased tendency for gastric ulcers. A serous objection to this theory, as
mentioned by the researchers themselves, is the problem of measuring sustained arousal
due to the constant interference of normal homeostatic reflexes; thus, the theory might
have limited scientific value as it seems difficult to test experimentally.
A related, though not identical concept has been promoted by McEwen, using ‘allostasis’
to denote the constantly changing activity in the adaptive systems of the body in response
to internal or external demands (268). Thus, ‘allostasis’ has a more general meaning
than homoeostasis; it seems to include both behavioral responses, as well as alterations
of the homeostatic levels (i.e., ‘homeodynamics’ according to Goldstein (155)).
‘Allostatic load’ is a general term for chronic altered activity in the adaptive systems,
possibly contributing to disease processes; for instance, hypertension is regarded a
‘shut down-failure’. Compared with CATS, this theory seems to be less concerned
with the cognitive aspects of stress, and focused more on the possible harmful effects
of chronic altered stress responses.
5.1.3 The concept of CFS as a disorder of sustained arousal
That CFS might be regarded a ‘stress disorder’ has been proposed earlier (72, 169),
and similar models have recently been developed for other diseases of unknown, but
possibly related origin, such as fibromyalgia (424). In this thesis, we have provided
evidence of altered sympathetic nerve activity among CFS patients, indicating
disturbances of CNS autonomic control characterized by abnormal homeostat resetting
(see 4.2.6). Thus, our results seem to support an intimate relationship between CFS
and stress/distress. More specifically, we present the following postulate as a starting
point for further elaboration:
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Chronic fatigue syndrome is a condition of disproportionate compensatory CNS
responses to common stressors. Dependent on the theoretical framework, this condition
might be labeled ‘chronic distress’ (155), ‘sustained arousal’ (421), or ‘allostatic load
shut-down failure’ (268).
Without intending to signal a preference for any particular theory, in the following we
will consequently use the term ‘sustained arousal’.
5.2 The CFS sustained arousal theory
In the following, we discuss the CFS sustained arousal theory in relation to prior research
on pathophysiology, as presented more in detail above (see 1.3.2). In accordance with
Prins, we find it convenient to differentiate between predisposing factors, precipitating
factors, and factors that might be regarded as perpetuating or as a mere consequence of
the disease process (318). Thereafter, we propose a unifying model for the CFS
pathophysiology, and discuss its implications for further research.
5.2.1 Predisposing factors
Genetics
The functioning of the sympathetic nervous system is highly dependent upon several
genes; at some loci, even single nucleotide polymorphism may considerably influence
its abilities, probably explaining - among other things – why individuals respond
differently to pharmacological antihypertensive treatment (459). In other words, our
stress reactions are to some extent genetically determined (155).
A couple of twin studies indicate that several abnormalities described among CFS
patients are a consequence of inheritance, and not of the current disease process (244,
256, 313, 344). Still, there is increasing evidence of a specific hereditary component to
this disease (63, 404). Interestingly, recent research indicates an association to
polymorphisms of genes involved in CNS control of autonomic and endocrine effector
systems, including the genes for monoamine oxidase (MAO) and catechol-O-
methyltransferase (COMT) (154, 373). Thus, it is tempting to suggest a possible
relationship between a specific genetic background, a certain stress responsiveness,
and an increased risk of developing CFS.
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Personality
Some studies report that certain personality traits, like perfectionism and con-
scientiousness, predispose for CFS (319, 440). Concurrently, it is widely accepted that
personality constitutes an important factor in how we respond to both physical (238)
and mental (32) stressors; on a more theoretical level, personality seem to influence
both the perception of stressful stimuli and the available coping strategies (155, 421).
The influence of CNS noradrenergic systems on personality is generally recognized
(102). Novel evidence suggests a relationship between certain alleles at the MAO-A
genetic locus and specific behavioral traits, such as ‘straightforwardness’, ‘con-
scientiousness’, ‘novelty seeking’ and ‘reward dependence’ (334, 364). Likewise,
polymorphisms of the alpha2-adrenoreceptor gene may have related implications (74).
Unfortunately, the MAO-A gene was excluded from parts of the extensive genetic
analysis of CFS patients recently performed by CDC researchers (154). Thus, putative
genetic risk factors of CFS may be partly mediated through its effect on personality,
making personality an interactive, or perhaps even confounding, variable.
Earlier experiences of stress
In humans as well as animals, the responses to a certain stress factor are highly dependent
upon the unconscious influences of prior experience (118, 155) (see 5.1). Experiences
in early developmental phases seem to be of particular importance (59). In other words,
the CNS centers controlling these responses are amenable to learning. The mechanisms
of such learning might be that of classical conditioning, creating – for instance - an
association between stress responses and symbolic cue that does not threaten homeo-
stasis. Eventually, operant conditioning might establish a link between a stressor and a
certain coping strategy.
The additive effect of repeated exposure to different physical and psychosocial stressors
is highly unpredictable. Still, if CFS is regarded as a condition of disproportionate
stress responsiveness, one should expect a high incidence of potentially stressful
situations among CFS patients prior to the outbreak of the disease. Some preliminary
evidence seems to support this notion (412). Also, the close similarities between CFS
and the Gulf war-syndrome, affecting veterans from the 1991 war in the Persian gulf,
are notable in this regard (27), as well as the ‘neurocirculatory asthenia’ described
among World war II soldiers (138). However, comprehensive research is still lacking.
Cultural issues
Although disputed, the prevalence of fatigue syndromes seems to be higher in well-
developed countries than in underdeveloped (371), at least partially justifying the notion
of CFS as a disease of ‘modern civilization’. In this context, the question is whether
certain aspects of the present Western culture might expose the population to a specific
kind of stress or distress, increasing the risk of developing CFS in some individuals.
Naturally, this problem seems more related to philosophy than physiology. Still, it is
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not a novel perspective; in the 1800s, neurasthenia was partly attributed to the strain on
the nervous system caused by industrialization (400).
Individualism seems to be a hallmark of postmodern culture (46). Western man has to
a great extent emancipated himself from religious, moral, social and political authorities
and traditions, and is – as never before – free to follow his own will and desire (122).
This is often regarded as a positive situation of increased freedom, but it is also related
to potential side effects, as recognized among medical academics (281) as well as
religious leaders (321). Paradoxically, his freedom also dooms the postmodern individual
to elect everything; from his clothes, friends and leisure activities to his career, moral
standards and religious beliefs. To put it succinctly: he is free and forced to elect and
construct his own self. John Donne seems to be outdated: in our time, man is (or at least
behaves as) an island, entire of itself...
It seems reasonable that this cultural phenomenon might promote an experience of
stress in some individuals. First, the unlimited freedom of choice might be perceived as
a threatening one: a vast amount of choices implies a vast amount of possible wrong
choices as well. In other words, man is burdened by an overwhelming responsibility;
the success in life, or eventually the lack of success, is entirely dependent upon his own
decisions. Second, whereas social support might strengthen our coping abilities (423),
there is a short step from individualism to loneliness and helplessness, reducing our
potential to handle stressors appropriately (420).
There is at present no firm empirical evidence linking these cultural phenomena to the
development of CFS. Interestingly though, some researchers do find that dilemmas –
which normally flourish in a setting of unlimited possible choices - may be related to
the disorder (180).
5.2.2 Precipitating factors
Infection
There are intriguing similarities between CFS and post-polio syndrome (44). In the
latter, fatigue is a common complaint, as well as cognitive impairments such as reduced
memory, concentration and attention. The clinical features of ‘epidemic’ outbreaks of
CFS (see 1.1.2) show strikingly similarities to epidemics of polio, and similar
disturbances in the HPA axis, cardiovascular regulation and EEG activity have been
demonstrated in both groups of patients. Post-polio syndrome, like CFS, seems to be
aggravated by physical as well as emotional stress (45). Autopsies of polio victims
reveal lesions in multiple brain stem areas, among others the reticular formation,
paraventricular nucleus and locus ceruleus (44). Thus, Bruno and coworkers put forward
a common fatigue theory based upon brain stem dysfunction, in particular influencing
the ‘activation system’ in the reticular formation
A similar way of reasoning was presented by Dickinson, putatively relating CFS to
infectious damage of the reticular activation system of the brain stem (101). Notably,
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the microorganisms that seem most strongly associated with CFS outbreaks – Epstein-
Barr virus and enteroviruses (2, 61) – commonly affect the central nervous system
(446). Thus, in our setting, one might speculate that certain infectious agents may
specifically distort the neuronal areas responsible for the compensatory responses to
common stressors. To our knowledge, no research has addressed this possibility.
Alternatively, the relationship between CFS and infections may be regarded as non-
specific (2). Here, it should be emphasized that long-lasting infections, as well as other
states of chronic inflammations, constitute considerable stressors, provoking patterned
responses from the CNS (357). Due to a combination of predisposing factors, some
individuals might be particularly prone to long-lasting stress responses. Moreover, in
such a situation, the responses may easily become unconsciously associated with non-
stressful stimuli through the mechanisms of classical conditioning, resulting in sustained
arousal (169).
It should be emphasized that altered stress responses may have profound influence
upon the immune system, as further outlined below. Thus, the findings of viral
reactivation and increased antibody levels in CFS might be an effect of the disease
process rather than a cause (50, 120). Eventually, one might speculate that viral
reactivation leads to inflammation that further enhances the stress response, thus
establishing a vicious circle.
Strenuous physical exercise
Strenuous physical exercise, such as during high level competition, represent a great
challenge to homeostasis, and therefore requires a comprehensive compensatory
response (155). Post-exertional malaise is an almost uniform complaint of all CFS
patients, and also included in the CDC definition (142, 318). Surprisingly, we have not
found any report specifically addressing strenuous physical exercise as a possible
precipitating factor. There is, however, striking similarities between CFS and the
overtraining syndrome, which is described by some researchers as a stress related
disorder (6). In addition to fatigue and exercise intolerance, overtrained athletes have
increased sympathetic cardiovascular modulation (18) increased oxidative stress (129),
a predominance of Th2 vs. Th1 immune response (230), and a blunted HPA axis
responsiveness (6). Thus, there is strong cause to believe that CFS and overtraining
might have some pathophysiologic mechanisms in common.
Severe psychosocial stress
According to some reports, CFS might be precipitated by critical life events (e.g. loss
of spouse) (345, 412). In addition, the similarities with asthenia resulting from combat
experience should be underlined in this paragraph as well (27, 138). Such events
constitute severe stressors, eliciting emotional and behavioral as well as autonomic
and endocrine responses (155). As for unspecific infections, the dynamics of such a
response depends on predisposing factors as well as the influence of classical and operant
conditioning; in susceptible individuals, the end result may be sustained arousal.
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5.2.3 Consequences of the disease process and perpetuating factors
Molecular biology
Binding of catecholamines to the beta-adrenoceptors of white blood cells activates
mainly the cAMP/protein kinase A-pathway, in turn controlling the activity of several
important transcription factors (115). Therefore, a profound change in gene expression
of peripheral mononuclear cells, as have been documented in recent CFS studies (124,
439), is – in principle - fully coherent with a hypothesis of enhanced sympathetic and
adreno-medullary activity as a central pathogenetic component.
The detailed mechanisms possibly relating altered sympathetic nerve activity to the
observed alterations in gene transcription remain to be explored. However, recent reports
may shed light on some possible links; e.g., activation of the estrogen receptor, as has
been reported among CFS patients (124), can be achieved through catecholaminergic
stimulation of the cAMP/protein kinase A-pathway (293). Furthermore, acute
psychosocial stress in healthy subjects has been shown to have significant effects on
the transcription of several genes in circulating leukocytes (276).
Immunity and infection
Various kinds of stress seem to have profound effects on the immune system; main
findings include attenuated cellular immunity (including decreased NK cell activity
and decreased T-cell responsiveness), as well as a tendency towards reactivation of
latent herpesviruses, including the Epstein-Barr virus (50, 152). Similar changes have
been reported in the aftermath of strenuous physical exercise (233). Some of these
effects might be attributed to increased sympathetic nerve activity and heightened levels
of catecholamines. For instance, during acute psychological stress, norepinephrine and
epinephrine seem responsible for recruiting different subset of NK-cells (34). During
exercise, increased levels of catecholamines are probably important for leukocyte
redistribution and functional alteration (349, 361). When taken together, increased
sympathetic nerve activity seems to promote a shift towards Th2 immune responses at
the cost of Th1 immune responses.
Intriguingly, such a shift corresponds neatly with the recent findings among CFS patients
(see 1.3.2) (63, 301, 372). Furthermore, it has been reported that psychosocial stress in
CFS patients attenuates the cytokine production induced by the infusion of lipo-
polysaccarides (171). One underlying mechanism might be diminished responsiveness
to catecholamines, as was indeed demonstrated by Kavelaars and co-workers who
reported reduced cytokine production by monocytes from CFS patients when stimulated
with the beta2-adrenoreceptor agonist terbutaline (208). This finding, in turn, may be
explained by receptor downregulation due to permanently increased plasma levels of
catecholamines.
Thus, immune dysfunction in CFS may be regarded an epiphenomena rather than a
casual factor, as has been pointed out by others (66). Furthermore, the findings of
increased activity of intracellular microorganisms in CFS patients, most convincingly
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reported for enteroviruses (61) and Mycoplasma-species (284), might be fully explained
by reactivation of latent infections due to immunological alterations (225).
It has not escaped our attention that the immune dysfunction of CFS may also contribute
to patients’ complaints and therefore should be regarded as a perpetuating factor. For
instance, diverse cytokines have effects on CNS; e.g., IL-1 induces fever through an
influence on the hypothalamus (301), and IL-6 may provoke fatigue (170). Cate-
cholamines stimulate secretion of the latter, also within the CNS, by binding to the
beta-adrenoceptor of antigen presenting cells (115). Interestingly, Gupta and co-workers
did find experimental evidence of a correlation between IL-6 production and patients’
complaints of fatigue (170).
Oxidative stress
Increased levels of catecholamines promote oxidative stress by an auto-oxidation
mechanism resulting in reactive intermediate products, which in turn may give rise to
free oxygen radicals (99). This mechanism probably contributes significantly to myocyte
damage after myocardial infarction, and explains some of the detrimental effects of
enhanced sympathetic nerve activity related to this condition. Interestingly, the cardiac
cell disturbances – which are partly reversible - are characterized by increased lipid
content and mitochondrial swelling (99, 257), similar to what has been reported in
skeletal muscles of CFS patients (19). In fact, recent evidence suggests a direct link
between increased levels of catecholamines and skeletal muscle damage (49, 260, 287).
Thus, the increased oxidative stress documented in CFS patients (212, 328) may be a
consequence of increased sympathetic outflow and increased catecholamine levels,
probably contributing to symptoms such as muscle pain and postexertional malaise
(197). There is also potential for a vicious circle, as pain and tissue damage caused by
oxidative stress may enhance sympathetic outflow further through simple reflex
mechanisms.
Skeletal muscle function
Since stress elicits a concomitant autonomic and behavioral response, there should be
an intimate relationship between CNS autonomic centers and CNS areas involved in
skeletal muscle control. Thus, in rats, experimental evidence indicates that
adrenoreceptor stimulation elicits behavioral activation through a coordinated influence
on motor areas and areas responsible for motivation and arousal (393, 395). Nor-
epinephrinergic neurons in locus ceruleus, as well as epinephrinergic neurons in other
sites, probably play important roles in this process (392, 394). Accordingly, in other
species, the activity in these neurons increases in response to salient events (320), and
also in relation to the decision to act (67). A related finding among rats is the presence
of neurons in the paraventricular nucleus of hypothalamus and other nearby areas that
seem to exert concomitant influence of motor neurons and sympathetic preganglionic
neurons (214).
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Therefore, if CFS is a state of sustained arousal and permanently altered CNS control
system, disturbances of skeletal muscle nerve control is an expected finding, and has
indeed been documented in several reports (91, 162, 314, 351, 367, 380). Such
disturbances may be reinforced through the mechanisms of operant conditioning,
explaining the ‘kinesiophobia’ documented in CFS patients (288, 369); i.e., repeated
experiences of insufficient motor responses to common stressors will weaken the
perceived coping abilities, possibly resulting in a state of ‘helplessness’ (421). These
CNS mechanisms may also be directly involved in the development of fatigue sensations:
in healthy subjects, fatigue induced by isometric exercise is related to an increase of
electrical activity in brain motor areas prior to a repeated motor performance, possibly
being a result of altered concentration or attention (350).
However, peripheral interaction between stress responses and motoric systems might
also contribute to the skeletal muscle dysfunction in CFS. Catecholamines strongly
influence the excitability of striated muscle cell membrane (177), probably explaining
why psychological distress alters EMG records of skeletal muscle (330); these findings
also constitute a possible explanation for the altered skeletal muscle excitability reported
by Jammes and co-workers in CFS patients (197). Moreover, the reported pathology of
skeletal muscles in CFS patients (197) may increase afferent neural activity, and thereby
enhance resting sympathetic outflow through a reflex mechanism (324). Concurrently,
such enhanced activity may contribute to muscle damage (49, 260, 287), thus establishing
a vicious circle. Skeletal muscle atrophy due to inactivity might of course set up a
negative self-reinforcing process as well.
Neuroimaging
The postulated disturbances of CNS autonomic control should be reflected in
neuroimaging studies. Indeed, there are reports of altered perfusion (83), metabolism
(414) and transmitter activity (70, 449) in brain areas responsible for stress responses.
However, only a few of the functional neuroimaging studies among CFS patients have
explored brain activity during mental stress, and none of them have investigated CNS
responses to bodily stress, like exercise or orthostasis.
Sleep
There are indications of sleep disturbances among CFS patients (131, 261, 415), although
firm evidence is lacking. Importantly, sleep is controlled by brain stem areas that also
participate in stress responses. For instance, norepinephrinergic neurons in the locus
ceruleus probably play a key role in the regulation of sleep rhythms (43), causing
different gene expressions in cortical neurons during sleep and wakefulness (65).
Interestingly, in patients with cardiac failure, sleep disturbances seem to be correlated
with enhanced sympathetic nerve activity (452), and similar findings have recently
been reported among CFS patients (174). Thus, we propose that distorted sleep among
CFS patients is a consequence of the disease process, possibly contributing to their
general feeling of malaise.
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Cognitive function
According to Goldstein, distress implies consciousness (155) and must therefore involve
cortical brain areas (43); likewise, conscious mental processes are presupposed in the
CATS theory of stress (118). Consequently, given our postulate of CFS as a disorder of
sustained arousal, it should follow that there are disturbances of cognitive functions.
Although evidence is conflicting, there seems to be a general agreement of some
cognitive impairment in CFS, particularly affecting memory, attention and information
processing (93, 272). Altered attention directly points to a disturbance of the reticular
substance, which is important for the modulation and ‘gating’ of afferent impulses
from all kinds of receptors (43). In situations perceived as a threat to homeostasis, the
reticular substance automatically focuses our attention to the sensory information of
particular relevance, and concurrently inhibits transmission of irrelevant information.
Thus, it is reasonable that a state of sustained arousal will have severe impacts upon
one’s attention abilities.
Reports of further weakening of cognitive abilities during stressful situations, such as
exercise (26, 232), is in line with a sustained arousal theory of CFS as well. The reported
beneficial effect of cognitive and endocrine effects of clonidine under conditions of
high arousal among CFS patients were interpreted as being indicative of supersensitive
postsynaptic alpha2-adrenoceptors in the brain (277), seeming to contradict our postulate.
However, as central alpha2-stimulation primarily has a sympathoinhibitory effect (155),
these results are equally adherent with a hypothesis of enhanced, centrally driven
sympathetic neurotransmission in CFS.
Cognitive dysfunction in CFS may also interact complexly with mechanisms of
conditioning. For instance, there is evidence of discrepancies between perceived and
actual cognitive abilities among these patients (271), a phenomenon that seems to be
fully explicable within the CATS theory (118, 421). For instance, a limited cognitive
impairment might cause repeated experiences of insufficient coping strategies, thus
negatively influencing the perceived coping abilities through operant conditioning.
Importantly, this perceived impairment is a stronger predictor of outcome than the real
impairment, resulting in a self-fulfilling prophecy. Such processes seem to be of general
importance, influencing healthy individuals as well. For instance, well-trained subjects
have a lower increase of epinephrine during bouts of exercise than sedentary controls
(221). Experimental evidence indicates that the mechanism underlying this different
response is a training-status dependent change in perceived exertion, rather than the
magnitude of exertion itself.
Dysfunctional cognitive processes analogue to those described above might underlie
similar reports of discrepancies between perceived and real abilities in other areas (13,
288, 369). Furthermore, they give a clue as to why patients’ attributions seem to be
related to actual outcome (187), and why cognitive therapy is proven effective (10,
100, 114, 280, 315, 335, 443). Finally, they contribute to vicious circles: sustained
arousal inhibits cognitive functions, whereas cognitive impairments weaken coping
strategies and thereby contribute to sustained arousal.
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Psychology and psychiatry
The state of anxiety, neuroanatomically related to limbic brain areas (43), elicits strong
stress responses. Thus, it is reasonable to suppose similarities in the pathophysiologies
of anxiety disorders and CFS. Indeed, the enhancement of central noradrenergic
transmission seems to be a key feature of the former, explaining findings of increased
plasma catecholamines (60). In panic disorder as well as post traumatic stress disorder,
there is evidence of an alteration in alpha2-adrenoceptor sensitivity (14, 39). Amygdala,
which is reciprocally connected with locus ceruleus and nearby brain stem centers,
seems to be the most important brain area for conditioned fear responses, whereas
other parts of the limbic system (e.g. anterior cingulate cortex) have a modulating role
(60). Gupta recently proposed that there is similar amygdalar fear conditioning in CFS
patients (169), whereas Naschitz and colleagues reported a specific pattern of cardiac
autonomic control in CFS patients that closely resembles what has been previously
observed in anxiety disorders (283).
Epidemiologic research also seems to support a relationship between CFS and anxiety
disorders, demonstrating much higher prevalence of panic disorders and generalized
anxiety among CFS patients than in the general population, both in adults (130, 235)
and adolescents (149).
Endocrinology
It is universally accepted that stress has profound endocrine consequences, mainly
influencing plasma levels of adrenal hormones (155). During acute distress, enhanced
sympathetic outflow to the adrenal marrow releases epinephrine, whereas the activation
of the HPA axis ensures a release of glucocorticoids from the adrenal cortex. However,
several other endocrine mechanisms are involved as well; for instance, in one study,
marital conflict was related to increased plasma levels of epinephrine, norepinephrine,
growth hormone and ACTH (217).
The observations of increased plasma levels of epinephrine among CFS patients in this
thesis and in other reports (208, 413) comply with our postulate of sustained arousal.
The documented attenuation of the HPA axis might seem more conflicting. However,
whereas acute stress is related to increased levels of glucocorticoids, chronic stress
might have the opposite effect, as thoroughly reviewed by Yehuda (454). The mechanism
seems to be one of habituation, involving the adrenal cortex and the pituitary, as well as
the hypothalamus. As for the latter, there is evidence of increased cortisol receptor
density, possibly amplifying the negative feedback control and reducing plasma cortisol
concentration (455). It is important to note, however, that a possible alteration of HPA
responsiveness may be highly dependent on both the quality and the dynamics of the
stressors. Thus, in experimental settings, HPA responsiveness is more affected when
animals are exposed to repetitions of the same stimulus, whereas a regimen that
constantly changes the nature and severity of the stimulus may not cause a blunted
response. In some experiments, the attenuation of the HPA axis also blunted the response
to a novel, acute stressor. In humans, similar findings have been reported among Vietnam
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soldiers (36), parents of fatally ill children (139) and subjects having highly stressful
occupational tasks (427). Furthermore, there are reports of reduced HPA responsiveness
in posttraumatic stress disorder (454), although the evidence at this point is somewhat
conflicting (245, 311).
When viewed as a whole, we conclude that attenuated HPA responsiveness is coherent
with our postulate of CFS as a disorder of sustained arousal. Furthermore, blunted HPA
activity during new, acute stressors may contribute to patients’ complaints. Of interest
here is a study by Streeten, reporting a high prevalence of fatigue among patients with
hypocortisolism and ‘delayed orthostatic hypotension’ (397). The characteristics of the
latter group are not well outlined in terms of physiology, but there seem to be several
similarities to the cardiovascular responses demonstrated among CFS patients in this
thesis.
Circulation
As discussed thoroughly above, the findings of cardiovascular disturbances in CFS
patients reported in this thesis directly suggest sustained arousal. This complies with
studies reporting higher resting blood pressure as well as increased sympathetic
modulation of heart rate and total peripheral resistance among healthy humans during
acute and chronic distress, both in test situations (252, 253) and during sleep (174). In
mice, there is even experimental evidence of subtle myocardial damage during conditions
of chronic psychosocial stress (84).
We found only two studies that were specifically aimed at exploring the cardiovascular
autonomic responses during exercise in CFS patients (81, 376). Neither the experimental
design nor the analytic methods were highly sophisticated. Nevertheless, their results
are in line with ours: Cordero and co-workers found attenuated parasympathetic
modulation of heart rate during dynamic exercise (81), whereas Soetekouw and
colleagues reported attenuated cardiovascular responses during isometric exercise (376).
As outlined above, different stressors elicit discrete, patterned CNS responses (155).
Therefore, these reports – indicating opposite sympathetic responses to dynamic and
isometric exercise - are not surprising in a state of presumed dysfunctional CNS control,
and should not be interpreted as conflicting evidence.
Cardiovascular disturbances may readily explain some complaints among CFS patients,
as demonstrated in this thesis. Also, it should be noted that vicious circles may be
established within the cardiovascular system as well. As outlined above, the fatigue-
induced inactivity causes deconditioning characterized by slight hypovolemia, which
in turn amplifies the stress responses to orthostasis and supposedly contributes to a
state of sustained arousal (see 4.2.1).
Thermoregulation
Increased body temperature, as demonstrated in this thesis, is consistent with a state of
sustained arousal, as is evident in both animal (42, 104) and human research (41). The
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mechanism seems to be the heightening of the set-point and a subsequently increased
sympathetic outflow to thermoregulatory effector organs, complying with our results
discussed above (see 4.1.5).
Recent reports have demonstrated increased acetylcholine-induced vasodilatation among
CFS patients (203, 378). This result can have many explanations (379), but does not
rule out enhanced sympathetic neurotransmission to skin arterioles. The vasodilative
effect of acetylcholine is not caused by a direct effect on vascular smooth muscles, but
is mediated through increased NO production in the nearby endothelial cells (155). NO
is a potent vasodilator; in addition to having a direct effect on smooth muscle cells, this
chemical compound also antagonizes the effect of norepinephrine. Thus, in subjects
with high resting sympathetic tone, an increased NO production should cause a greater
relative increase in blood flow as compared to subjects with low resting sympathetic
tone, fitting neatly with the reported experimental results (203, 378).
Fatigue
A CFS theory should, of course, also address the hallmark of this disease, namely the
experience of disabling fatigue. Although still sparse, there is evidence suggesting a
possible relationship to the state of sustained arousal. For instance, strenuous, fatiguing
physical exercise causes a long-lasting increase in plasma norepinephrine and
sympathetic heart rate modulation during the recovery period (146, 399). However,
more firm evidence seems to have emerged from animal studies. In rats, painful and
inescapable stimuli alter the serotonin (5-HT) neurotransmission in different brain stem
and limbic areas, such as the raphe nucleus (266), the amygdala (4) and the hippocampus
(3). Interestingly, the nature of the stress influences the responses; the less controllability,
the greater the increase in serotoninergic outflow (30). Furthermore, the experience of
incontrollable stress strongly influences the neurotransmitter as well as the behavioral
response to novel stressors (29). Comparable experiments have demonstrated that
chronic stress alters the brain level of CRH and norepinephrine as well (58, 275, 407).
Concurrently, neurons utilizing these transmitters mutually influence each other. For
instance, serotoninergic neurons from the dorsal raphe nucleus activate CRH neurons
in the paraventricular nucleus (107, 336), whereas these CRH neurons in turn seem
capable of activating noradrenergic neurons in the locus ceruleus (227).
Interestingly, alterations in the levels of these three neurotransmitters have also been
regarded as a potential element of a neuronal substrate underlying the experience of
fatigue (407). In particular, an increased level of serotonin has been attributed to the
experience of fatigue after exercise (11, 88), and was indeed demonstrated among CFS
patients in one study (69). Thus, in conclusion, there is scientific evidence, although
still immature, suggesting a possible causal relationship between sustained arousal and
the experience of fatigue.
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5.2.4 A unifying model of CFS pathophysiology
In summing up the above discussion, we present the following unifying model for the
pathophysiology of CFS (Figure 12):
A. Predisposing factors of CFS are factors that increase the risk of developing sustained
arousal; thus they are related to the CNS mechanisms concerning stress responses.
The most important are:
a. Genetic polymorphisms whose products are involved in stress-induced
neurotransmission, such as MAO and COMT polymorphism.
b. Personality traits that influence the interpretation of, experience of, and
response to stressful situations, such as perfectionism.
c. Prior experiences of stressful situations that modulate CNS stress responses
through classical and operant conditioning, such as combat experience.
d. Cultural phenomena that might be perceived as stressful or interfere with
coping abilities, such as ‘choice overload’ and loneliness in postmodern
societies.
B. Precipitating factors of CFS are factors that elicit strong CNS stress responses,
eventually developing into sustained arousal due to either neuronal damage or the
mechanisms of classical and operant conditioning. The most important are:
a. Infections involving microorganisms such as Epstein-Barr virus and entero-
viruses.
b. Strenuous physical exercise, such as high-level competition.
c. Severe psychosocial stress, such as loss of a spouse.
C. Consequences of sustained arousal and perpetuating factors are phenomena that
are caused by sustained arousal and eventually contribute to its persistence. The
most important are:
a. Transcriptional activation in leukocytes due to peripheral catecholaminergic
stimulation.
b. A Th2 vs Th1 immune response predominance due to peripheral cate-
cholaminergic stimulation. In turn, this might lead to:
i. Altered cytokine production, contributing to fatigue and thermo-
regulatory disturbances.
ii.Reactivation of intracellular microorganisms.
c. Oxidative stress due to peripheral catecholaminergic stimulation. In turn,
this might lead to:
i. Muscle damage, contributing to pain and postexertional malaise.
ii.Enhanced afferent neurotransmission, amplifying stress responses
(vicious circle).
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d. Skeletal muscle dysfunction, due to both altered CNS neurotransmission in
motor areas and peripheral catecholaminergic stimulation. In turn, this might
lead to:
i. Muscle atrophy, amplifying stress responses when moving (vicious
circle).
e. Altered perfusion, metabolism and transmitter activity in all brain areas
involved in stress responses, due to altered CNS neurotransmission.
f. Sleep disturbances, due to altered CNS neurotransmission in brain stem areas.
In turn, this might lead to:
i. General feeling of malaise.
g. Cognitive impairments, due to altered CNS neurotransmission in cortical
areas. In turn, this might lead to:
i. Discrepancies between perceived and real abilities due to mechanisms
of conditioning, contributing to feelings of helplessness.
ii.Weakened coping abilities, amplifying stress responses (vicious
circle).
h. Anxiety-like pathophysiology, due to altered CNS neurotransmission in
limbic areas.
i. Attenuated HPA axis activity, due to alterations in hypothalalamic, pituitary
and adrenal regulatory mechanisms. In turn, this might lead to:
i. Blunted HPA axis responsiveness to acute stressors, contributing to
patients’ complaints.
j. Circulatory abnormalities due to altered set-points of homeostatic control
circuits and subsequently altered peripheral catecholaminergic stimulation.
In turn, this might lead to:
i. Orthostatic intolerance and related symptoms.
ii.Sedentary deconditioning, amplifying stress responses during
orthostatis (vicious circle).
k. Thermoregulatory abnormalities due to altered set-points of homeostatic
control circuits and subsequent altered peripheral catecholaminergic
stimulation. In turn, this might lead to:
i. Symptoms of thermoregulatory disturbances.
l. Fatigue, due to altered CNS neurotransmission in brain stem/limbic areas.
It is important to emphasize that this model allows heterogeneity of causal factors
among individuals. In other words: sustained arousal is seen as a ‘final common
pathway’, whereas the combination of predisposing, precipitating and perpetuating
factors may vary from patients to patient. Thus, in some subjects, the most important
causal factors may be, for instance, a certain genetic trait combined with acute infections,
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Figure 12. The sustained arousal theory of CFS. The figure should be regarded a
simplified overview putatively relating current research findings to disturbances of
CNS autonomic control, cf. figure 3. V.C.=Vicious circle.
whereas in others, prior experience combined with severe psychosocial stress might
have the greatest impact. This may result in a confusingly non-uniform clinical picture.
The proposed CFS sustained arousal theory seems attractive for different reasons. First,
it is constructed upon a synthesis of the present knowledge concerning pathophysiology,
and unifies findings from different research traditions; it even seems to share some
concepts with theories proposed within the field of psychoanalysis (110). Second, it is
based upon and coherent with contemporary stress theories, which in turn is firmly
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Consequences of sustained arousal and perpetuating factors
rooted in empirical research. Third, it seems to possess a kind of ‘face validity’ when
appraised in relation to patients’ uniform experience of an inability to respond properly
to the physical and mental challenges of daily life (178, 375). Fourth, it allows for the
deduction of testable hypotheses that might be subjected to further research, as outlined
below (see 5.2.5).
However, there are also some objections. The CFS sustained arousal theory implies a
biopsychosocial construct that – although widely accepted by most experts - has been
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met with skepticism from patient organizations as well as some practitioners and
researchers (318, 436). At a more general level, our suggested model challenges a
stable, 1:1 relationship between cause and effect, and thereby seems to oppose a more
mechanistic approach to biology and medicine. As stated by Manu: «… more than any
other issue in contemporary medicine, chronic fatigue syndrome reflects the unresolved
conflict between the mechanistic and the biopsychosocial construct of illness» (262).
The model proposed here infer heterogeneity of causality as well as clinical presentation,
and allow symptom severity to be relative to the extent of stressor exposure. Thus, the
model views CFS as a kind of maladaption, in many respects analogous to the
phenomenon of ‘loudspeaker feedback’: When a microphone is placed in the vicinity
of a loudspeaker, even small noises will be amplified through positive feedback, resulting
in an earsplitting sound and functional ‘breakdown’. However, there are no specific
failures of the different electronic devices per se; no ‘pathologies’ of cables or
connections. The problem results from maladaption; the equipment set-up is
inappropriate relative to the initial noise recorded by the microphone. The problem
might be solved by lowering surrounding sounds. In terms of CFS, reducing all external
stimuli that might provoke a stress response. However, a more definite solution would
be to change the abilities within the feedback loops, by moving the microphone away
from the loudspeaker or reducing the gain of the electronic amplifier device; the latter
would correspond to a ‘down-tuning’ of the stress responses within the brain.
5.2.5 Suggestions for further research
Based upon the CFS sustained arousal theory explained above, we will in the following
present a few hypotheses and shortly outline possible methods for testing them. The
list is not complete, but indicates some natural directions for further research.
1) Certain polymorphisms of genes whose products are involved in stress-induced
neurotransmission are more common among CFS patients than healthy controls.
Leukocyte DNA must be collected from well-defined populations of patients and
controls. A search for polymorphisms should be governed by updated knowledge of
the genetic basis for stress responses. Commercial kits for such genomic studies are
generally easily available.
2) CFS patients have experienced more stressful situations prior to disease onset than
patients suffering from other long-lasting disease. A prospective, population-based
design would be preferable due to possible recall bias, but is inconvenient on the practical
side. Stressful situations should be operationalized, and might include for instance
prematurity, early long-time kindergarden affiliation, other serious diseases, trauma,
death of a family member and abuse.
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3) Acute Epstein-Barr virus infection elicits a more comprehensive stress response
than other viral infections of similar clinical presentation. Patients with verified acute
EBV infection and patients with acute viral pharyngitis of other origin could undergo
experiments (e.g. head-up tilt-test) to assess their autonomic nerve activity when exposed
to stressors. Subjects from the two groups should be matched according to their CRP
level, to ensure an equally extensive inflammatory reaction.
4) When exposed to physical stress (such as orthostasis or physical exercise), perfusion,
metabolism and transmitter activity in brain areas responsible for stress responses
differs among CFS patients and controls. Of particular interest are the serotoninergic
and norepinephrinergic pathways in the brain stem and limbic structures. Modern
neuroimaging technology makes such studies feasible.
5) Cognitive therapy specifically designed to abolish sustained arousal are more effective
in the treatment of CFS than unspecific cognitive therapy. To our knowledge, the
effectiveness of different cognitive treatment approaches has not been subjected to
research. The design should be randomized and controlled.
6) The characteristics of the baroreflex and the cardiopulmonary reflex differ among
CFS patients and controls during rest and orthostatic stress due to set-point alterations.
A logical continuation of our own research is to explore further the characteristics of
the homeostatic control circuits responsible for volume and blood pressure regulations
in CFS patients and controls. A possible analytic tool would be the mathematical
technique of transfer function analyses, which could be applied to already recorded
data from the LBNP and HUT experiments (416).
7) The blood volume and the central venous pressure are comparable among CFS
patients and controls, but the renin-angiogensin-aldosteron activity is not. As the renal
secretion of renin is controlled through sympathetic efferents, one should expect
increased activity in a state of sustained arousal, but no alterations of blood volume or
central venous pressure. Such an experiment would require invasive recordings.
8) When comparing CFS patients to controls, acute physical stress (orthostasis, physical
exercise) and mental stress will cause a greater increase in directly recorded sympathetic
outflow to skin and skeletal muscles as well as plasma turnover of epinephrine and
norepinephrine. Measurements of cardiovascular and thermoregulatory variables, as
performed in this thesis, provide only indirect information on sympathetic nerve activity,
and are therefore prone to several interpretational caveats. To the best of our knowledge,
no study has applied the technique of microneurography which allows direct recordings
of sympathetic skin and skeletal muscle activity. Likewise, only a few researchers have
performed catecholamine measurements (208, 413), none of them using recently
available, advanced methods of kinetics.
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9) Pharmaceutical inhibition of brain centers eliciting the stress response will improve
the functional abilities of CFS patients and normalize the hemodynamics in stressful
situations.  The alpha2-adrenoceptor agonist clonidine is an effective antihypertensive
drug due to central inhibition of sympathetic outflow. Anxiolytic drugs, like benzo-
diazepines, also exert an inhibitory effect on the relevant brain stem centers. As far as
we know, their effect in CFS patients has not been subjected to systematic trials. Such
trials should focus on the changes of functional capacities, but should also assess whether
the stress responses have normalized, possibly using cardiovascular function as an
indicator.
Finally, it should be pointed out that the CFS sustained arousal theory – if proven
correct – might have implications beyond its present application. Related diseases,
such as fibromyalgia, might be fully explicable within the same theoretical framework
(421). Furthermore, similar models seem valuable for providing new insight into totally
different areas, for instance hypertension and the mechanisms underlying placebo effects.
Finally, it might even contribute to a deeper understanding of body-mind interactions
in general.
Thus, we have come full circle, recalling the introductory quotation of Harvey: «For
every affection of the mind that is attended with either pain or pleasure, hope or fear, is
the case of an agitation whose influence extends to the heart…» Or, to cite his
contemporary Blaise Pascal (1623-62):
«Le coeur a ses raisons que la raison ne connaît point.»
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